<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">87742</article-id>
<article-id pub-id-type="doi">10.7554/eLife.87742</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.87742.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Developmental Biology</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Stem Cells and Regenerative Medicine</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>SMARCAD1 and TOPBP1 contribute to heterochromatin maintenance at the transition from the 2C-like to the pluripotent state</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7209-7612</contrib-id>
<name>
<surname>Sebastian-Perez</surname>
<given-names>Ruben</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nakagawa</surname>
<given-names>Shoma</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tu</surname>
<given-names>Xiaochuan</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aranda</surname>
<given-names>Sergi</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pesaresi</surname>
<given-names>Martina</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gomez-Garcia</surname>
<given-names>Pablo Aurelio</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alcoverro-Bertran</surname>
<given-names>Marc</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gomez-Vazquez</surname>
<given-names>Jose Luis</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carnevali</surname>
<given-names>Davide</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Borràs</surname>
<given-names>Eva</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sabidó</surname>
<given-names>Eduard</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martin</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nissim-Rafinia</surname>
<given-names>Malka</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4777-986X</contrib-id>
<name>
<surname>Meshorer</surname>
<given-names>Eran</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Neguembor</surname>
<given-names>Maria Victoria</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3488-6228</contrib-id>
<name>
<surname>Di Croce</surname>
<given-names>Luciano</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4207-5097</contrib-id>
<name>
<surname>Cosma</surname>
<given-names>Maria Pia</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a5">5</xref>
<xref ref-type="aff" rid="a6">6</xref>
<xref ref-type="aff" rid="a7">7</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology</institution>, Dr. Aiguader 88, Barcelona 08003, <country>Spain</country></aff>
<aff id="a2"><label>2</label><institution>Universitat Pompeu Fabra (UPF)</institution>, Dr. Aiguader 88, Barcelona 08003, <country>Spain</country></aff>
<aff id="a3"><label>3</label><institution>Department of Genetics, The Alexander Silberman Institute of Life Sciences</institution>, Edmond J. Safra Campus, <institution>The Hebrew University of Jerusalem</institution>, Jerusalem 91904, <country>Israel</country></aff>
<aff id="a4"><label>4</label><institution>The Edmond and Lily Safra Center for Brain Sciences</institution>, Edmond J. Safra Campus, <institution>The Hebrew University of Jerusalem</institution>, Jerusalem 91904, <country>Israel</country></aff>
<aff id="a5"><label>5</label>ICREA, <institution>Pg. Lluis Companys 23</institution>, Barcelona 08010, <country>Spain</country></aff>
<aff id="a6"><label>6</label><institution>Bioland Laboratory, Guangzhou Regenerative Medicine and Health Guangdong Laboratory</institution>, Guangzhou 510005, <country>China</country></aff>
<aff id="a7"><label>7</label><institution>CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences</institution>, Guangzhou 510530, <country>China</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Postovit</surname>
<given-names>Lynne-Marie</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Queens University</institution>
</institution-wrap>
<city>Kingston</city>
<country>Canada</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Cheah</surname>
<given-names>Kathryn Song Eng</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of Hong Kong</institution>
</institution-wrap>
<city>Hong Kong</city>
<country>Hong Kong</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Corresponding author. Email: <email>pia.cosma@crg.es</email> (M.P.C.)</corresp>
<fn id="n1"><label>#</label><p>Co-first authors</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2023-06-06">
<day>06</day>
<month>06</month>
<year>2023</year>
</pub-date>
<volume>12</volume>
<elocation-id>RP87742</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-04-15">
<day>15</day>
<month>04</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-04-17">
<day>17</day>
<month>04</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.04.15.537018"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2023, Sebastian-Perez et al</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Sebastian-Perez et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-87742-v1.pdf"/>
<abstract>
<title>Abstract</title><p>Chromocenters are established after the 2-cell (2C) stage during mouse embryonic development, but the factors that mediate chromocenter formation remain largely unknown. To identify regulators of 2C heterochromatin establishment, we generated an inducible system to convert embryonic stem cells (ESCs) to 2C-like cells. This conversion is marked by a global reorganization and dispersion of H3K9me3-heterochromatin foci, which are then reversibly formed upon re-entry into pluripotency. Profiling the chromatin-bound proteome (chromatome) by genome capture of ESCs transitioning to 2C-like cells, we uncover chromatin regulators involved in <italic>de novo</italic> heterochromatin formation. We identified TOPBP1 and investigated its binding partner SMARCAD1. SMARCAD1 and TOPBP1 associate with H3K9me3-heterochromatin in ESCs. Interestingly, the nuclear localization of SMARCAD1 is lost in 2C-like cells. SMARCAD1 or TOPBP1 depletion in mouse embryos lead to developmental arrest, reduction of H3K9me3 and remodeling of heterochromatin foci. Collectively, our findings contribute to comprehending the maintenance of chromocenters during early development.</p>
</abstract>

</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Early mammalian development is a dynamic process that involves large-scale chromatin reorganization (<italic><xref ref-type="bibr" rid="c1">1</xref></italic>). Blastomeres acquire a defined cell identity through the activation of a subset of genes and specific epigenetic modifications. Among the latter, there is a tailored control over histone H3 lysine 9 trimethylation (H3K9me3), a hallmark of the transcriptionally repressed constitutive heterochromatin (<italic><xref ref-type="bibr" rid="c2">2</xref>, <xref ref-type="bibr" rid="c3">3</xref></italic>). During the first cleavage stages, constitutive heterochromatin reorganizes in the nucleus to form highly compacted chromocenters (<italic><xref ref-type="bibr" rid="c4">4</xref>, <xref ref-type="bibr" rid="c5">5</xref></italic>). Systematic identification of the underlying factors involved in <italic>de novo</italic> heterochromatin establishment and maintenance - thus chromocenter compaction-is still lacking, mostly because of the minuscule amount of material available during embryogenesis.</p>
<p>Embryonic stem cells (ESCs) can fluctuate back to a 2-cell embryo-like (2C-like) state under defined culture conditions (<italic><xref ref-type="bibr" rid="c6">6</xref></italic>). Although ESCs can spontaneously revert their fate to resemble early embryogenesis, this process happens at a very low frequency (<italic><xref ref-type="bibr" rid="c6">6</xref></italic>). Recently, early mouse embryo development has been modelled with high efficiency after downregulation of chromatin assembly factors (<italic><xref ref-type="bibr" rid="c7">7</xref></italic>) or modulation of key developmentally regulated genes in ESCs (<italic><xref ref-type="bibr" rid="c8">8</xref>-<xref ref-type="bibr" rid="c11">11</xref></italic>). ESCs can efficiently be converted into 2C-like cells by the overexpression of a single murine transcription factor, Dux (<italic><xref ref-type="bibr" rid="c11">11</xref></italic>). Interestingly, decondensation of HP1α foci and of chromocenters in 2C<sup>+</sup> were previously reported, suggesting that 2C<sup>+</sup> cells can be used to study the remodeling of heterochromatin foci (<italic><xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c12">12</xref></italic>). Here, using the Dux-dependent reprogramming system, we show that 2C-like cells can be used as a model system to investigate <italic>de novo</italic> chromocenter formation and dynamics. Using chromatin proteomics, we profiled the dynamic changes occurring in the chromatin-bound proteome (chromatome) during 2C-like cell reprogramming and identified factors potentially involved in chromocenter reorganization. H3K9me3-marked heterochromatin foci in 2C-like cells generated via Dux overexpression became larger and decreased in number during the reprogramming of ESCs to 2C-like cells. The chromocenters re-formed upon transition of 2C-like cells into ESC-like cells. We identified the DNA TOPoisomerase II Binding Protein 1 (TOPBP1) and the chromatin remodeler SWI/SNF-Related, Matrix-Associated Actin-Dependent Regulator Of Chromatin, Subfamily A, Containing DEAD/H Box 1 (SMARCAD1) to be associated with H3K9me3 in heterochromatin foci of ESCs. The association of SMARCAD1 was reduced upon entry of ESCs in the 2C-like state, although SMARCAD1 nuclear localization was recovered after 2C-like state exit. Depletion of SMARCAD1 and of TOPBP1 induced mouse embryo developmental arrest, which was accompanied by a remodeling of the heterochromatin foci. Our results suggest a contributing role of SMARCAD1 and of TOPBP1 activity in the maintenance of heterochromatin formation during early development.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Chromatin-bound proteome profiling allows the identification of dynamic chromatome changes during 2C-like cell reprogramming</title>
<p>To explore the molecular driving events for the establishment of constitutive heterochromatin during embryo development, we generated stable ESC lines carrying doxycycline-inducible cassettes that drive expression of either Dux (Dux-codon altered, CA) or luciferase (control) (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>). These ESC lines also carry an EGFP reporter under the control of the endogenous retroviral element MERVL long terminal repeat (2C::EGFP) (<italic><xref ref-type="bibr" rid="c7">7</xref></italic>). The EGFP reporter allows the purification of 2C-like cells (hereinafter named 2C<sup>+</sup>) and low <italic>Dux</italic> expressing cells, which are negative for MERVL reporter expression (2C<sup>−</sup>) (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>). 2C<sup>−</sup> cells were reported to be an intermediate population generated during 2C-like reprogramming (<italic><xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c14">14</xref></italic>). During the reprogramming process, in contrast to 2C<sup>−</sup> cells, 2C<sup>+</sup> cells do not show DAPI-dense chromocenters (<italic><xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c11">11</xref></italic>). Therefore, we can study <italic>de novo</italic> chromocenter formation by following the transition of 2C<sup>+</sup> cells toward an ESC-like state, thus modelling in culture the epigenetic reprogramming that occurs during mouse early development.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Fig. 1.</label>
<caption><title>Chromatin-bound proteome profiling allows the identification of dynamic chromatome changes during 2C-like cell reprogramming.</title>
<p>(A) Schematic representation of the samples collected to perform the identification of protein on total DNA (iPOTD) workflow. LC-MS/MS, liquid chromatography-tandem mass spectrometry. (B) Reproducibility between replicates of independent chromatome preparations. Correlation between replicate 1 and replicate 2 from the 2C<sup>−</sup> condition is shown. <italic>R</italic> indicates Pearson’s R. (C) Correlation matrix showing reproducibility among independent replicates of -EdU, Luc, 2C<sup>−</sup> and 2C<sup>+</sup> protein abundances. Hierarchical clustering analysis of the individual replicates is also shown. PCC, Pearson’s correlation coefficient. (D) Principal component analysis (PCA) of the chromatome dataset. Each point corresponds to a single replicate. Beige arrow indicates the 2C-like reprogramming trajectory. (E) Protein enrichment analysis of the comparison between 2C<sup>+</sup> and Luc chromatomes. Red dots indicate known regulators of the 2C-like state, which were found enriched in the 2C<sup>+</sup> chromatome (upper panel), and novel factors which were found depleted from the 2C<sup>+</sup> chromatome (lower panel). Dashed lines indicate log<sub>2</sub> FC ± 2. (F) Protein enrichment analysis of the comparison between 2C<sup>−</sup> and Luc chromatomes. Red dots indicate known regulators of the 2C-like state, which were found enriched in the 2C<sup>−</sup> chromatome. Dashed lines indicate log<sub>2</sub> FC ± 2. (G) Protein enrichment analysis of the comparison between 2C<sup>+</sup> and 2C<sup>−</sup>chromatomes. Red dots indicate novel factors which were found depleted from the 2C<sup>+</sup> chromatome. Dashed lines indicate log<sub>2</sub> FC ± 2. (H) Heat map representation of the chromatin-bound abundance of pluripotency transcription factors, 2-cell-specific factors and transcriptional regulators in Luc, 2C<sup>−</sup> and 2C<sup>+</sup> cells. Data are presented as log<sub>2</sub> FC of PSM values to -EdU. PSM, peptide spectrum match. (I) Venn diagram indicating the overlap between the identified proteins enriched in Luc, 2C<sup>−</sup> and 2C<sup>+</sup> chromatomes after SAINT analysis. Specifically, an average enrichment value was computed from the respective pairwise comparisons (i.e., Luc vs 2C<sup>−</sup>; Luc vs 2C<sup>+</sup>; 2C<sup>−</sup> vs Luc; 2C<sup>−</sup> vs 2C<sup>+</sup>), and proteins were selected on the basis of a minimum of FC ≥ 2. The solid line highlights the 397 proteins enriched in the Luc and 2C<sup>−</sup> chromatomes that were not enriched in the 2C<sup>+</sup> chromatome. (J) Gene ontology analysis of the commonly enriched chromatin-bound proteins identified in (I). (K) Distribution of the top 50 chromatin-bound proteins identified in the Luc and 2C<sup>−</sup> chromatomes ranked by log<sub>2</sub> FC. (L) Functional protein network of TOPBP1 interactors. TOPBP1 and SMARCAD1 nodes are colored in red. The black node border indicates chromatin remodeling function. Network edges indicate the degree of confidence prediction of the interaction. Protein interaction data were retrieved from the STRING database (Szklarczyk et al., 2017).</p></caption>
<graphic xlink:href="537018v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>After culturing the Dux-CA line with doxycycline (Dox), the number of 2C-like cells increased to &gt; 60 % as compared to luciferase control cells (<xref rid="figs1" ref-type="fig">fig. S1A-D</xref>). Dux overexpression resulted in the loss of DAPI-dense chromocenters and loss of the pluripotency transcription factor OCT4 (<xref rid="figs1" ref-type="fig">fig. S1E</xref>), in accordance with previous reports (<italic><xref ref-type="bibr" rid="c6">6</xref>, <xref ref-type="bibr" rid="c7">7</xref></italic>). These changes were accompanied by an upregulation of specific genes of the 2-cell transcriptional program such as endogenous <italic>Dux</italic>, MERVL and major satellites (MajSat) (<xref rid="figs1" ref-type="fig">fig. S1F</xref>). Additionally, we looked at cell cycle progression in the heterogeneous population of cells generated after Dux overexpression since it has been previously shown that spontaneous 2C-like cells have an altered cell cycle (<italic><xref ref-type="bibr" rid="c15">15</xref></italic>). 2C<sup>−</sup> cells displayed a cell cycle profile comparable to that of luciferase cells, whereas 2C<sup>+</sup> cells accumulated in the G2/M cell cycle phase (<xref rid="figs1" ref-type="fig">fig. S1G</xref>) with a much-reduced S phase consistent in several clonal lines (<xref rid="figs1" ref-type="fig">fig. S1H</xref>). Overall, these data indicate that the 2C<sup>+</sup> line we generated recapitulates known features of 2C-like cells.</p>
<p>Having characterized the Dux-CA line, we aimed to identify potential chromatin-associated factors involved in the <italic>de novo</italic> establishment of heterochromatin. For that, we performed DNA-mediated chromatin purification coupled to tandem mass spectrometry for the identification of proteins on total DNA (iPOTD) (<italic><xref ref-type="bibr" rid="c16">16</xref>, <xref ref-type="bibr" rid="c17">17</xref></italic>). We captured the whole genome labelled with 5-ethynyl-2’-deoxyuridine (EdU) and identified candidate proteins differentially enriched in the 2C-like chromatin-bound (chromatome) fraction (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>). We analyzed the chromatome of 2C<sup>+</sup>, 2C<sup>−</sup> and luciferase (Luc) populations to characterize the chromatin-bound proteome profile of these distinct states. We first confirmed that we could enrich the iPOTD preparations for chromatin proteins, such as histone H3, and devoid them of cytoplasmic ones, such as vinculin (<xref rid="figs2" ref-type="fig">fig. S2A-C</xref>). We identified a total of 2396 proteins, suggesting an efficient pull-down of chromatin-associated factors (<xref rid="figs2" ref-type="fig">fig. S2D</xref> and <xref rid="tbl1" ref-type="table">Table S1</xref>). Chromatin-resident proteins, such as core histones and histone variants, were comparably enriched in all +EdU replicates (<xref rid="figs2" ref-type="fig">fig. S2E</xref> and <xref rid="tbl1" ref-type="table">Table S1</xref>). Pearson’s correlation coefficients (PCC) and principal component analysis (PCA) of independent replicates of 2C<sup>+</sup>, 2C<sup>−</sup> and Luc samples showed consistent results regarding the abundance of the proteins detected (<xref rid="fig1" ref-type="fig">Fig. 1B-D</xref> and <xref rid="tbl1" ref-type="table">Table S1</xref>). Interestingly, Luc replicates clustered separately from 2C<sup>+</sup> and 2C<sup>−</sup> conditions, indicating significant changes in the chromatomes of these fractions (<xref rid="fig1" ref-type="fig">Fig. 1C</xref>, <xref rid="fig1" ref-type="fig">1D</xref>).</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1</label>
<caption><p>– List of top oligos used for cloning shRNAs</p></caption>
<graphic xlink:href="537018v1_tbl1.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<p>We then ranked the identified chromatin-associated factors according to their fold change to interrogate the differences in protein-chromatin interactions in the 2C<sup>+</sup>, 2C<sup>−</sup> and Luc chromatomes (<xref rid="fig1" ref-type="fig">Fig. 1E-G</xref>). Members of the ZSCAN4 (Zinc finger and SCAN domain containing 4) family of proteins, that are well-characterized markers of the 2C stage (<italic><xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c11">11</xref>, <xref ref-type="bibr" rid="c18">18</xref>, <xref ref-type="bibr" rid="c19">19</xref></italic>), were identified among the top enriched factors in the 2C<sup>+</sup> chromatome (<xref rid="fig1" ref-type="fig">Fig. 1E</xref>, <xref rid="fig1" ref-type="fig">1F</xref>, <xref rid="fig1" ref-type="fig">1H</xref>). ZSCAN4 family members, such as ZSCAN4F and ZSCAN4C, were found associated with chromatin already in the 2C<sup>−</sup> chromatome (<xref rid="fig1" ref-type="fig">Fig. 1F</xref>), supporting previous findings (<italic><xref ref-type="bibr" rid="c14">14</xref></italic>). However, we identified regulators of 2C-like cells such as TET1, the non-canonical Polycomb (PcG) Repressor Complex 1 (PRC1) member PCGF6, the TGF-β regulator SMAD7 and the heterochromatic H4K20me3 methyltransferase SUV420H2 depleted from the 2C<sup>+</sup> chromatome when compared to the 2C<sup>−</sup> (<italic><xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c20">20</xref>, <xref ref-type="bibr" rid="c21">21</xref></italic>) (<xref rid="fig1" ref-type="fig">Fig. 1E</xref>, <xref rid="fig1" ref-type="fig">1G</xref>, <xref rid="fig1" ref-type="fig">1H</xref>). The pluripotency transcription factors NANOG, OCT4, STAT3, SOX2 and ESRRB were, as expected, exclusively enriched in the 2C<sup>−</sup> and Luc chromatomes (<xref rid="fig1" ref-type="fig">Fig. 1H</xref>). We also identified several transcriptional regulators and epigenetic enzymes differentially enriched in the 2C<sup>+</sup>, 2C<sup>−</sup> and Luc chromatomes (<xref rid="fig1" ref-type="fig">Fig. 1H</xref>). Of note, we identified marked differences in the enrichment for H3K9 histone methyltransferases SUV39H1 and SUV39H2 (<xref rid="fig1" ref-type="fig">Fig. 1H</xref>). SUV39H2 gradually increased its abundance on chromatin as Luc cells converted to 2C<sup>−</sup> and, ultimately, to 2C<sup>+</sup> (<xref rid="fig1" ref-type="fig">Fig. 1H</xref>). Contrarily, SUV39H1 was overall less abundantly chromatin-bound, although with a slight enrichment in the 2C<sup>−</sup> chromatome (<xref rid="fig1" ref-type="fig">Fig. 1H</xref>). Altogether, these data indicate that ESC reprogramming toward 2C-like state correlates with a major reorganization of the chromatin-bound proteome.</p>
<p>We used the Significance Analysis of INTeractome (SAINT) algorithm (<italic><xref ref-type="bibr" rid="c22">22</xref></italic>) to further interrogate protein-chromatin interactions in the iPOTD datasets. To identify molecular drivers of chromocenter reorganization, we compared the enriched proteins in the 2C<sup>+</sup>, 2C<sup>−</sup> and Luc chromatomes (<xref rid="fig1" ref-type="fig">Fig. 1I</xref> and <xref rid="tbl1" ref-type="table">Table S1</xref>). We identified a total of 397 proteins shared by the 2C<sup>−</sup> and Luc chromatomes that were not enriched in the 2C<sup>+</sup> chromatome (<xref rid="fig1" ref-type="fig">Fig. 1I</xref> and <xref rid="tbl1" ref-type="table">Table S1</xref>). We focused on analyzing this cluster since chromocenters are present in 2C<sup>−</sup> and Luc cells. This protein cluster included gene ontology (GO) terms associated with RNA and chromatin binding, active remodeling activity (e.g. ATPase activity), repressive chromatin (e.g. heterochromatin condensed chromosome, negative regulation of gene expression), and pluripotent stem cell identity (e.g. response to LIF, stem cell maintenance, blastocyst growth) (<xref rid="fig1" ref-type="fig">Fig. 1J</xref>). To identify putative factors responsible for chromocenter reorganization, we ranked the commonly identified proteins included in 2C<sup>−</sup> and Luc chromatomes according to their fold change (<xref rid="fig1" ref-type="fig">Fig. 1K</xref>). Notably, this protein cluster included known transcriptional regulators such as the DNA methyltransferase DNMT3L, the bromodomain-containing protein BRD2, the core pluripotency factor OCT4 and the DNA topoisomerase 2-binding protein 1, TOPBP1 (<xref rid="fig1" ref-type="fig">Fig. 1K</xref>). We focused our attention on TOPBP1, since topoisomerases control genome structure and folding (<italic><xref ref-type="bibr" rid="c23">23</xref></italic>). We asked if the lack of topoisomerase activity could promote 2C<sup>+</sup> cell induction. Thus, we treated ESCs with camptothecin (CPT) and ICRF-193, which are inhibitors of DNA topoisomerases I and II, respectively (<italic><xref ref-type="bibr" rid="c24">24</xref>, <xref ref-type="bibr" rid="c25">25</xref></italic>). Inhibition of topoisomerase II alone increased the number of 2C<sup>+</sup> cells 1.5-fold (<xref rid="figs3" ref-type="fig">fig. S3A</xref>) and triggered a prominent cell cycle arrest in the G2/M phase (<italic><xref ref-type="bibr" rid="c25">25</xref>, <xref ref-type="bibr" rid="c26">26</xref></italic>) (<xref rid="figs3" ref-type="fig">fig. S3B</xref>). Simultaneous inhibition of topoisomerases I and II resulted in an enhanced effect, leading to a 2.4-fold increase in the fraction of 2C<sup>+</sup> cells (<xref rid="figs3" ref-type="fig">fig. S3A, S3C</xref>). These results motivated us to further investigate TOPBP1 network. TOPBP1 has been shown to interact with chromatin remodelers such as the SWI/SNF-like remodeler SMARCAD1 in yeast and human cells (<italic><xref ref-type="bibr" rid="c27">27</xref>, <xref ref-type="bibr" rid="c28">28</xref></italic>) (<xref rid="fig1" ref-type="fig">Fig. 1L</xref>). We then investigated TOPBP1 and SMARCAD1 as potential candidate factors controlling the remodeling of chromocenters.</p>
</sec>
<sec id="s2b">
<title>Entry in the 2C-like state is characterized by the remodeling of H3K9me3 heterochromatic regions</title>
<p>To study remodeling of the chromocenters, we asked about the reorganization of heterochromatic regions upon reprogramming of ESCs into 2C<sup>+</sup> cells. H3K9me3 is a well-known pericentric heterochromatin histone modification that prominently associates with constitutive heterochromatin (<italic><xref ref-type="bibr" rid="c2">2</xref>, <xref ref-type="bibr" rid="c3">3</xref>, <xref ref-type="bibr" rid="c29">29</xref>, <xref ref-type="bibr" rid="c30">30</xref></italic>). H3K9me3 can therefore be used as marker for chromocenters. H3K9me3 foci in 2C<sup>+</sup> cells were morphologically distinct from those of 2C<sup>−</sup> cells (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>). They were 2.3-fold fewer (3.89 ± 0.19 foci/nucleus) (<xref rid="fig2" ref-type="fig">Fig. 2B</xref>), and occupied 2.4-fold larger area (4.76 ± 0.33 µm<sup>2</sup>) in 2C<sup>+</sup> as compared with both ESCs (8.88 ± 0.30 foci/nucleus; 1.99 ± 0.07 µm<sup>2</sup>) and 2C<sup>−</sup> cells (8.72 ± 0.25 foci/nucleus; 1.93 ± 0.08 µm<sup>2</sup>) (<xref rid="fig2" ref-type="fig">Fig. 2C</xref>). These results suggest that H3K9me3 heterochromatin undergoes massive spatial reorganization, during the reprogramming of ESCs into 2C-like state. Importantly, the levels of H3K9me3 remain unchanged among ESCs, 2C<sup>−</sup> and 2C<sup>+</sup> cells, indicating that the remodeling of chromocenters was not due to loss of H3K9me3 (<xref rid="figs3" ref-type="fig">fig. S3D</xref>). The increased size of the H3K9me3 foci and the reduction in the number of H3K9me3 foci per nucleus might be due to the decompaction or fusion of several chromocenters.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Fig. 2.</label>
<caption><title>Entry in the 2C-like state is characterized by the remodeling of H3K9me3 heterochromatin, which is reverted upon 2C<sup>+</sup> exit.</title>
<p>(A) Representative immunofluorescence images of the 2C::EGFP reporter and H3K9me3 in 2C<sup>−</sup> and 2C<sup>+</sup> cells. Scale bar, 2 µm. (B) Quantification of the number of H3K9me3 foci in ESCs, 2C<sup>−</sup> and 2C<sup>+</sup> cells. Data are presented as scatter dot plots with line at mean ± SD (n &gt; 3 independent cultures, ESCs = 103 cells, 2C<sup>−</sup> = 170 cells and 2C<sup>+</sup> = 119 cells). <italic>P</italic> &lt; 0.0001**** by one-way ANOVA (Tukey’s multiple comparisons test). (C) Quantification of H3K9me3 foci area in ESCs, 2C<sup>−</sup> and 2C<sup>+</sup> cells. Data are presented as scatter dot plots with line at mean ± SD (n &gt; 3 independent cultures, ESCs = 1712 foci, 2C<sup>−</sup> = 1445 foci and 2C<sup>+</sup> = 340 foci). <italic>P</italic> &lt; 0.0001**** by one-way ANOVA (Tukey’s multiple comparisons test). (D) Voronoi tessellation rendering of super-resolution images of DNA in 2C<sup>−</sup> and 2C<sup>+</sup> cells. Full nuclei (left; scale bar, 1 µm) and zoomed images (right; scale bar, 400 nm) are shown. (E) Biaxial density plot showing mean Voronoi density of DNA (inverse of the polygon area) as a measure of chromatin compaction and GFP intensity score in 2C<sup>−</sup> and 2C<sup>+</sup> cells. Cells with a GFP intensity score &gt; 0.2 are colored in green. Black dots indicate 2C<sup>−</sup> cells and green dots indicate 2C<sup>+</sup> cells. Each dot represents a single-cell (2C<sup>−</sup> = 23 cells and 2C<sup>+</sup> = 12 cells). (F) Quantification of the percentage of 2C-like cells 24 h, 48 h, 72 h and 7 days after 2C<sup>+</sup> cell sorting. The endogenous 2C-like fluctuation was used as the steady-state condition. Data are presented as mean ± SD (n = 3 independent experiments). <italic>P</italic> = 0.7656<sup>ns</sup>, <italic>P</italic> &lt; 0.0001**** by one-way ANOVA (Tukey’s multiple comparisons test). (G) Heat map representation of <italic>MERVL</italic>, <italic>Dux</italic>, <italic>Zscan4</italic>, <italic>Nelfa</italic>, <italic>Zfp352</italic> and <italic>Eif1a-like</italic> expression in luciferase (Luc), 2C<sup>−</sup> and 2C<sup>+</sup> sorted cells (entry) and in ESC-like cells at 24 h, 48 h, 72 h and 7 days (7d) after 2C<sup>+</sup> sorting. Data are presented as log<sub>2</sub> fold change (FC) values to luciferase detected by qRT-PCR. (H) Representative immunofluorescence images of H3K9me3 at 0 h (2C<sup>+</sup> before exit), 24 h, 48 h and 72 h after 2C-like state exit. Scale bar, 3 µm. (I) Quantification of the number of H3K9me3 foci in 2C<sup>+</sup> cells and at 24 h, 48 h and 72 h after 2C-like state exit. Data are presented as scatter dot plots with line at mean ± SD (n = 2 independent cultures, 2C<sup>+</sup> = 119 cells, same dataset plotted in <xref rid="fig2" ref-type="fig">Fig. 2B</xref>; ESC-like 24 h = 12 cells; ESC-like 48 h = 27 cells; ESC-like 72 h = 49 cells). <italic>P</italic> &lt; 0.0001**** by one-way ANOVA (Tukey’s multiple comparisons test). (J) Quantification of H3K9me3 foci area in 2C<sup>+</sup> cells and at 24 h, 48 h and 72 h after 2C-like state exit. Data are presented as scatter dot plots with line at mean ± SD (n = 2 independent cultures, 2C<sup>+</sup> = 340 foci, same dataset plotted in <xref rid="fig2" ref-type="fig">Fig. 2C</xref>; ESC-like 24 h = 168 foci; ESC-like 48 h = 238 foci; ESC-like 72 h = 605 foci). <italic>P</italic> &gt; 0.05<sup>ns</sup>, <italic>P</italic> &lt; 0.0001**** by one-way ANOVA (Tukey’s multiple comparisons test).</p></caption>
<graphic xlink:href="537018v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We then imaged global DNA organization with Stochastic Optical Reconstruction super-resolution Microscopy (STORM). DNA was labelled using the nucleotide analogue 5-ethynyl-2’-deoxycytidine (EdC) (<italic><xref ref-type="bibr" rid="c31">31</xref>, <xref ref-type="bibr" rid="c32">32</xref></italic>). DNA images were quantified by Voronoi tessellation analysis (<italic><xref ref-type="bibr" rid="c33">33</xref>, <xref ref-type="bibr" rid="c34">34</xref></italic>) which can precisely determine the DNA density based on the number of localizations in each Voronoi tessel (see Methods). Voronoi analysis showed a marked decrease in the localization density of the chromatin in 2C<sup>+</sup> cells (<xref rid="fig2" ref-type="fig">Fig. 2D</xref>). Furthermore, Voronoi analysis confirmed the decreased DNA density as a function of the GFP intensity in 2C<sup>+</sup> cells (<xref rid="fig2" ref-type="fig">Fig. 2E</xref>). Interestingly, 2C<sup>−</sup> cells were heterogeneous with respect to DNA density, with the majority of them showing low DNA density as compared with 2C<sup>+</sup> cells, suggesting that DNA might undergo decompaction prior to GFP activation (<xref rid="fig2" ref-type="fig">Fig. 2E</xref>). Overall, the DNA decompaction of the chromatin fibers in 2C<sup>+</sup> cells is in agreement with the chromatin landscape of early/late 2-cell embryos, which was reported to be more accessible by Assay for Transposase Accessible Chromatin with high-throughput sequencing (ATAC-seq) (<italic><xref ref-type="bibr" rid="c11">11</xref>, <xref ref-type="bibr" rid="c35">35</xref></italic>).</p>
</sec>
<sec id="s2c">
<title>H3K9me3 heterochromatin becomes rapidly formed following exit from the 2C-like state</title>
<p>We then asked whether 2C<sup>+</sup> cells could undergo the reverse transition, exiting the 2C-like state and subsequently re-entering pluripotency, thereby becoming ESC-like cells. To answer this question about the kinetics of the reverse transition, we followed the expression of EGFP in FACS-sorted 2C<sup>+</sup> cells 24 h, 48 h, 72 h and one week after sorting (<xref rid="fig2" ref-type="fig">Fig. 2F</xref>). Strikingly, over 60 % of the 2C<sup>+</sup> cells in culture lost the expression of the MERVL reporter 24 h after sorting. Moreover, 48 h after sorting, only 6 % of the cells still expressed the reporter, suggesting rapid repression of the 2C program, and quick re-establishment of the pluripotency network (<xref rid="fig2" ref-type="fig">Fig. 2F</xref>). 72 h and 7 days (7 d) after sorting, EGFP expression levels were comparable to those derived from the endogenous fluctuation (“<italic>steady state</italic>”) of ESC cultures (<xref rid="fig2" ref-type="fig">Fig. 2F</xref>). The decay in EGFP levels was accompanied by a downregulation of MERVL, endogenous <italic>Dux</italic>, <italic>Zscan4</italic>, <italic>Nelfa</italic>, <italic>Zfp352</italic> and <italic>Eif1a-like</italic> gene expression (<xref rid="fig2" ref-type="fig">Fig. 2G</xref>). These results indicate that 2C-like cells could revert their fate back to pluripotency after Dux overexpression, and that such transition occurs rapidly, as early as 24 h after sorting.</p>
<p>We then quantified the number and area of H3K9me3 foci during the 2C<sup>+</sup> to ESC-like transition (<xref rid="fig2" ref-type="fig">Fig. 2H-J</xref>). Our results indicate that chromocenters underwent rapid re-formation and increased in number (24 h: 9.67 ± 0.50; 48 h: 7.07 ± 0.46; 72 h: 8.82 ± 0.44 foci/nucleus) as compared to 2C<sup>+</sup> cells (3.89 ± 0.19 foci/nucleus), concomitantly to the loss of EGFP expression and to the exit from the 2C-like state (<xref rid="fig2" ref-type="fig">Fig. 2H</xref>, <xref rid="fig2" ref-type="fig">2I</xref>). The areas of chromocenters in ESC-like cells were similar across the different time-points analyzed (24 h: 1.54 ± 0.15; 48 h: 1.77 ± 0.14; 72 h: 1.75 ± 0.10 µm<sup>2</sup>) and smaller of those of 2C<sup>+</sup> cells (4.76 ± 0.33 µm<sup>2</sup>) (<xref rid="fig2" ref-type="fig">Fig. 2H</xref>, <xref rid="fig2" ref-type="fig">2J</xref>). These results suggest that the <italic>in vitro</italic> transition of the 2C<sup>+</sup> cells toward ESC-like state can be used as a model system to study chromocenter formation and chromatin reorganization occurring during early development.</p>
</sec>
<sec id="s2d">
<title>SMARCAD1 and TOPBP1 associate with H3K9me3 in ESCs and can maintain heterochromatin foci</title>
<p>The results of the iPOTD revealed TOPBP1 as a potential regulator of chromocenter reorganization. SMARCAD1 has been shown to interact with TOPBP1 in yeast and human cells (<italic><xref ref-type="bibr" rid="c27">27</xref></italic>) (<xref rid="fig1" ref-type="fig">Fig. 1K</xref>, <xref rid="fig1" ref-type="fig">1L</xref>). Interestingly, SMARCAD1, a SWI/SNF-like chromatin remodeler, is known to promote heterochromatin maintenance during DNA replication in terminally differentiated cells and silencing of endogenous retroviruses in ESCs (<italic><xref ref-type="bibr" rid="c36">36</xref>, <xref ref-type="bibr" rid="c37">37</xref></italic>). Nonetheless, it is not known whether SMARCAD1 plays a role in 2C-like fate transition and early embryo development.</p>
<p>We, therefore, decided to investigate SMARCAD1 and TOPBP1 in 2C<sup>+</sup> cells undergoing the transition to ESC-like cells where chromocenters are formed <italic>de novo</italic>. First, we evaluated whether SMARCAD1 was associated with TOPBP1 and/or H3K9me3 in ESCs, since TOPBP1 enriched in the 2C<sup>−</sup> and Luc chromatomes. We observed that both SMARCAD1 and TOPBP1 were associated with H3K9me3 (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>). However, we could not detect direct association between TOPBP1 and SMARCAD1, likely because of the suboptimal efficiency of available antibodies. Indeed, we cannot exclude their interaction as was shown previously in yeast and human cells (<italic><xref ref-type="bibr" rid="c27">27</xref></italic>). These data suggest SMARCAD1 and TOPBP1 to be potential regulators of H3K9me3 heterochromatin. Since SMARCAD1 is a chromatin remodeler, we then asked whether it localized at chromocenters in ESCs. We found that SMARCAD1 co-localized with H3K9me3 in heterochromatin foci of chromocenters in both ESCs and 2C<sup>−</sup> cells (<xref rid="fig3" ref-type="fig">Fig. 3B-D</xref>). In contrast, the expression of SMARCAD1 decreased in 2C<sup>+</sup> cells, where foci were much reduced in number (<xref rid="fig3" ref-type="fig">Fig. 3C</xref>, <xref rid="fig3" ref-type="fig">3D</xref>). We then asked whether SMARCAD1 depletion would increase the fraction of 2C<sup>+</sup> cells. We depleted <italic>Smarcad1</italic> using two independent sgRNAs, as confirmed comparing to a control sgRNA targeting luciferase (<xref rid="figs3" ref-type="fig">fig. S3E</xref>). SMARCAD1 depletion resulted in no major impact in the 2C<sup>+</sup> conversion either in the endogenous fluctuation or in Dux-induced cells when inspected at the steady state (<xref rid="fig3" ref-type="fig">Fig. 3E</xref>). We then investigated <italic>Smarcad1</italic>-depleted cells 24 h, 48 h, 72 h after the 2C<sup>+</sup> exit. Control KO cells (sgLuc) followed comparable exit kinetics as compared to non-transfected (NT) 2C<sup>+</sup> cells (<xref rid="figs3" ref-type="fig">fig. S3F</xref>). However, SMARCAD1 depletion resulted into a tendency to increased percentage of 2C<sup>+</sup> cells at all time point after the exit (<xref rid="fig3" ref-type="fig">Fig. 3F</xref>). Accordingly, the nuclear distribution of SMARCAD1 during exit from the 2C-like state changed. We first observed a diminution in SMARCAD1 signal as ESCs started to express the MERVL reporter, attaining severe reduction of SMARCAD1 in 2C<sup>+</sup> at the 24 h time point (<xref rid="fig3" ref-type="fig">Fig. 3H</xref>, <xref rid="fig3" ref-type="fig">3I</xref>). SMARCAD1 nuclear signal was then gradually recovered in the heterochromatin foci as 2C<sup>+</sup> cells were converted in ESC-like cells up to the 72 h from the exit, indicating reversibility of foci formation (<xref rid="fig3" ref-type="fig">Fig. 3H</xref>, <xref rid="fig3" ref-type="fig">3I</xref>). Surprisingly, the fraction of cells that repressed retroelements within 24 h from the 2C<sup>+</sup> exit (ESC-like at 24 h) already showed SMARCAD1 enriched foci (<xref rid="fig3" ref-type="fig">Fig. 3H</xref>). Altogether, these results suggest that SMARCAD1 was severely reduced from chromatin as ESCs progress to the 2C-like state and, later, SMARCAD1 nuclear distribution was reverted during the 2C<sup>+</sup> exit.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Fig. 3.</label>
<caption><title>SMARCAD1 associates with H3K9me3 in ESCs and its nuclear localization is reduced in the 2C-like state</title>
<p>(<bold>A</bold>) Co-immunoprecipitation (co-IP) experiment in ESCs using antibodies against H3K9me3 and TOPBP1. Western blots of H3K9me3, SMARCAD1 and TOPBP1 are shown. (<bold>B</bold>) Representative immunofluorescence images of H3K9me3 and SMARCAD1 in ESCs. Dashed lines indicate nuclei contour. Scale bar, 2 µm. Zoomed images of H3K9me3 and SMARCAD1 foci are shown for comparisons. Scale bar, 1 µm. (<bold>C</bold>) Representative immunofluorescence images of H3K9me3 and SMARCAD1 in 2C<sup>−</sup> and 2C<sup>+</sup> cells. Dashed lines indicate nuclei contour. Scale bar, 5 µm. Zoomed images of H3K9me3 and SMARCAD1 foci are shown for comparisons. Scale bar, 1 µm. (<bold>D</bold>) Co-localization analysis showing Manders’ coefficient between SMARCAD1 and H3K9me3 in ESCs, 2C<sup>−</sup> and 2C<sup>+</sup> cells. Data are presented as scatter dot plots with line at mean ± SD from ESC (n = 30), 2C<sup>−</sup> (n = 23), 2C<sup>+</sup> (n = 15) SMARCAD1-H3K9me3 foci. <italic>P</italic> &gt; 0.05<sup>ns</sup>, <italic>P</italic> = 0.0124* by one-way ANOVA (Dunnett’s multiple comparisons test). (<bold>E</bold>) Impact of targeting <italic>Smarcad1</italic> (sgSmarcad1) on the endogenous fluctuation and the Dux-induced 2C-like conversion. Data are presented as scatter dot plots with line at mean ± SD (n ≥ 3 independent CRISPR-Cas9 KO rounds). <italic>P</italic> = 0.4286<sup>ns</sup>, <italic>P</italic> = 0.0571<sup>ns</sup> by Mann-Whitney test. (<bold>F</bold>) Impact of targeting <italic>Smarcad1</italic> (sgSmarcad1) on the 2C-like cell percentage during the 2C<sup>+</sup> exit (24 h, 48 h and 72 h). Data are presented as scatter dot plots with line at mean ± SD (n = 5 independent CRISPR-Cas9 KO rounds). Individual points indicate scores of technical replicates. <italic>P</italic> = 0.1174<sup>ns</sup> at 24 h, <italic>P</italic> = 0.6158<sup>ns</sup> at 48 h, <italic>P</italic> = 0.6441<sup>ns</sup> at 72 h by multiple <italic>t</italic>-test. (<bold>G</bold>) Impact of targeting <italic>Topbp1</italic> (sgTopbp1) on the 2C-like cell percentage during the 2C<sup>+</sup> exit (24 h, 48 h and 72 h). Data are presented as scatter dot plots with line at mean ± SD (n = 5 independent CRISPR-Cas9 KO rounds). Individual points indicate scores of technical replicates. <italic>P</italic> = 0.0503<sup>ns</sup> at 24 h, <italic>P</italic> = 0.1589<sup>ns</sup> at 48 h, <italic>P</italic> = 0.2166<sup>ns</sup> at 72 h by multiple <italic>t</italic>-test. (<bold>H</bold>) Representative immunofluorescence images of SMARCAD1 and the 2C::EGFP reporter along the ESCs to 2C<sup>+</sup> reprogramming and during the 2C<sup>+</sup> exit (24 h, 48 h and 72 h). Dashed lines indicate nuclei contour. Scale bar, 4 µm. (<bold>I</bold>) SMARCAD1 integrated intensity analysis along the conversion of ESCs into 2C<sup>+</sup> cells and during the 2C<sup>+</sup> exit (24 h, 48 h and 72 h). Data are presented as mean ± SD. (<bold>J</bold>) Single-cell RNA-seq (scRNA-seq) expression profile of <italic>Smarcad1</italic> and <italic>Topbp1</italic> in pre-implantation mouse embryos. Data are presented as min-max boxplots with line at median. Each dot represents a single-cell. scRNA-seq data was obtained from ref. (<italic><xref ref-type="bibr" rid="c38">38</xref></italic>). RPKM, reads per kilobase of transcript per million mapped reads. (<bold>K</bold>) Representative immunofluorescence images of H3K9me3, SMARCAD1 and the 2C::EGFP reporter in <italic>Topbp1</italic> knockdown (shTopbp1) and control scramble (shScbl) cells. Scale bar, 5 μm. (<bold>L</bold>) Co-localization analysis showing Manders’ coefficient between H3K9me3 and SMARCAD1 in <italic>Topbp1</italic> knockdown (shTopbp1) and control scramble (shScbl) cells. Data are presented as mean ± SD (n = 2 independent cultures). <italic>P</italic> = 0.0066** by unpaired two-tailed Student’s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="537018v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We then used published single-cell RNA-seq (scRNA-seq) data (<italic><xref ref-type="bibr" rid="c38">38</xref></italic>) and found <italic>Smarcad1</italic> expression starting at the 2-cell stage, but increasing at the 4-cell stage embryo, which is the time when chromocenters compact during mouse embryo development (<xref rid="fig3" ref-type="fig">Fig. 3J</xref>). Notably, <italic>Topbp1</italic> showed a similar expression profile during preimplantation development (<xref rid="fig3" ref-type="fig">Fig. 3J</xref>). Similar to what observed for <italic>Smarcad1</italic>-depleted cells, <italic>Topbp1</italic>-depleted cells showed a tendency to increased percentage of 2C<sup>+</sup> cells at 24 h, 48 h and 72 h after 2C<sup>+</sup> exit (<xref rid="fig3" ref-type="fig">Fig. 3G</xref>). To further confirm these results and to investigate the role of TOPBP1 in the regulation of heterochromatin foci, we generated knocked-down ESC clones carrying shSmarcad1 or shTopbp1 (<xref rid="figs4" ref-type="fig">fig. S4A</xref>). We observed that the number of foci decreased and their area become larger after either knocking down <italic>Smarcad1</italic> or <italic>Topbp1</italic>, with respect to scramble controls (<xref rid="figs4" ref-type="fig">fig. S4B, S4C</xref>). Moreover, larger and fewer chromatin foci were visible in 2C<sup>+</sup> cells when compared to ESCs and 2C<sup>−</sup> cells (<xref rid="figs4" ref-type="fig">fig. S4D</xref>). We confirmed these results investigating <italic>Topbp1</italic>-depleted cells 24 h, 48 h, 72 h after the 2C<sup>+</sup> exit. We observed a decreased number of foci and their larger area at all time points analyzed after the exit (<xref rid="figs4" ref-type="fig">fig. S4E-G</xref>). These data suggest that heterochromatin foci are maintained in ESCs by SMARCAD1 and TOPBP1 and the depletion of both of these two proteins leads to a remodeling of the H3K9me3 foci.</p>
<p>Next, we asked about the functional interaction of SMARCAD1 and TOPBP1 and thus we evaluated the localization of SMARCAD1 after knocking down <italic>Topbp1.</italic> We found a significant reduction of SMARCAD1 co-localization with H3K9me3 in heterochromatin foci in <italic>Topbp1</italic>-depleted cells (<xref rid="fig3" ref-type="fig">Fig. 3K</xref>, <xref rid="fig3" ref-type="fig">3L</xref>), suggesting that SMARCAD1 and TOPBP1 might work as complex in the maintenance of heterochromatin foci.</p>
</sec>
<sec id="s2e">
<title>SMARCAD1 and TOPBP1 are necessary for early embryo development</title>
<p>Collectively, our findings suggested that both SMARCAD1 and TOPBP1 could be potential regulators of H3K9me3 heterochromatin in the 2C<sup>+</sup> transition. With this in mind, we aimed at investigating their function in preimplantation embryos. We injected zygote-stage (E0.5) embryos with morpholino antisense oligos (MO) targeting <italic>Smarcad1</italic> or <italic>Topbp1</italic> along with a scrambled control morpholino (Ctrl MO) (<xref rid="fig4" ref-type="fig">Fig. 4A</xref> and <xref rid="figs5" ref-type="fig">fig. S5A</xref>). As expected from MO, which acts by blocking translation, SMARCAD1 was degraded from the 2-cell stage, and a reduction in its levels was observed up to the 8-cell stage, in <italic>Smarcad1</italic> MO-injected embryos (<xref rid="figs5" ref-type="fig">fig. S5B, S5C</xref>). We could not image the degradation of TOPBP1 since available anti-TOPBP1 antibodies provide unspecific signal in immunofluorescence experiments. It is noteworthy that SMARCAD1 localizes exclusively in the nucleus of preimplantation embryos (<xref rid="figs5" ref-type="fig">fig. S5B</xref>). We observed that embryos developed slower than normal when <italic>Smarcad1</italic> was silenced (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>, <xref rid="fig4" ref-type="fig">4B</xref>). Indeed, they did not show the formation nor expansion of a blastocoel cavity at the early blastocyst stage, indicating a severe developmental delay (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>, <xref rid="fig4" ref-type="fig">4B</xref>). Notably, 68 % of the embryos deficient for <italic>Smarcad1</italic> arrested and did not develop until the late blastocyst stage (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>, <xref rid="fig4" ref-type="fig">4B</xref>). In the case of <italic>Topbp1</italic> silencing, we observed an even a more severe phenotype. All the embryos, 100 % of the <italic>Topbp1</italic> MO-injected ones, did not develop and arrest at 4-cell stage (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>, <xref rid="fig4" ref-type="fig">4B</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Fig. 4.</label>
<caption><title>SMARCAD1 and TOPBP1 downregulation impairs embryo development</title>
<p>(<bold>A</bold>) Representative embryos from control (Ctrl), <italic>Smarcad1</italic> and <italic>Topbp1</italic> morpholino-injected (MO) groups from 2-cell (E1.5) to late blastocyst stage (E5.5). Scale bar, 20 µm. (<bold>B</bold>) Quantification of the percentage of arrested or fully developed embryos at late blastocyst stage (E4.5). <italic>P</italic> &lt; 0.0001**** by Fisher’s exact test (Ctrl MO = 103 embryos, <italic>Smarcad1</italic> MO = 50 embryos, <italic>Topbp1</italic> MO = 65 embryos). (<bold>C</bold>) Representative immunofluorescence images of H3K9me3 in Ctrl and <italic>Smarcad1</italic> MO embryos at 8-cell stage (E2.5) embryos. Representative blastomere nuclei are shown. Scale bar, 5 µm. (<bold>D</bold>) Quantification of H3K9me3 mean fluorescence intensity in control (Ctrl, grey dots) and <italic>Smarcad1</italic> MO (red dots) embryos at 2-cell (E1.5) and 8-cell stage (E2.5). Data are presented as scatter dot plots with line at mean ± SD (2-cell: Ctrl MO = 12 embryos, <italic>Smarcad1</italic> MO = 15 embryos; 8-cell: Ctrl MO = 16 embryos, <italic>Smarcad1</italic> MO = 20 embryos). H3K9me3 signal was normalized to the average background signal. <italic>P</italic> = 0.0618<sup>ns</sup> and <italic>P</italic> = 0.0016** by unpaired two-tailed Student’s <italic>t</italic>-test. (<bold>E</bold>) Representative immunofluorescence images of SMARCAD1 in Ctrl and <italic>Topbp1</italic> MO embryos at 2-cell stage (E1.5) embryos. Representative blastomere nuclei are shown. Scale bar, 10 µm. (<bold>F</bold>) Quantification of SMARCAD1 mean fluorescence intensity in Ctrl and <italic>Topbp1</italic> MO embryos at 2-cell (E1.5). Data are presented as scatter dot plots with line at mean ± SD (Ctrl MO = 38 embryos, <italic>Topbp1</italic> MO = 44 embryos). SMARCAD1 signal was normalized to the average background signal. <italic>P</italic> &lt; 0.0001**** by unpaired two-tailed Student’s <italic>t</italic>-test. (<bold>G</bold>) Representative immunofluorescence images of SMARCAD1 in Ctrl and <italic>Topbp1</italic> MO embryos at 4-cell stage (E2.0) embryos. Representative blastomere nuclei are shown. Scale bar, 10 µm. (<bold>H</bold>) Quantification of SMARCAD1 mean fluorescence intensity in Ctrl and <italic>Topbp1</italic> MO embryos arrested at 4-cell. Data are presented as scatter dot plots with line at mean ± SD (Ctrl MO = 20 embryos, <italic>Topbp1</italic> MO = 31 embryos). SMARCAD1 signal was normalized to the average background signal. <italic>P</italic> &lt; 0.0001**** by unpaired two-tailed Student’s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="537018v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Since we observed that both SMARCAD1 and TOPBP1 were necessary for embryo developmental progression, we decided next to image H3K9me3 upon depletion of SMARCAD1 or of TOPBP1 (<xref rid="figs5" ref-type="fig">fig. S5A</xref>). H3K9me3 signal was significantly reduced in the embryos injected with <italic>Smarcad1</italic> MO already at the 8-cell stage (E2.5), almost one day earlier than early blastocyst (E3.5), when the developmental delay was morphologically visible (<xref rid="fig4" ref-type="fig">Fig. 4C</xref>, <xref rid="fig4" ref-type="fig">4D</xref> and <xref rid="figs5" ref-type="fig">fig. S5A</xref>). In <italic>Topbp1</italic> MO embryos, we did not observe decreased intensity of the H3K9me3 signal since the developmental arrest was present already at 4-cell stage and variation in this histone mark might be clearly measurable only starting from morula stage (<xref rid="figs5" ref-type="fig">fig. S5A, S5D, S5E</xref>). On the other hand, we analyzed HP1b, a major component of constitutive heterochromatin which binds to both DNA and to H3K9me3 (<italic><xref ref-type="bibr" rid="c39">39</xref>, <xref ref-type="bibr" rid="c40">40</xref></italic>). We observed a major remodeling of heterochromatin in both 2-cell and 4-cell Topbp1 MO arrested embryos, as indicated by the spreading and increased signal of HP1b (<xref rid="figs5" ref-type="fig">fig. S5F-S5I</xref>).</p>
<p>Finally, given that we observed SMARCAD1 reduction in heterochromatin foci in <italic>Topbp1</italic>-depleted cells (<xref rid="fig3" ref-type="fig">Fig. 3K</xref>, <xref rid="fig3" ref-type="fig">3L</xref>), we investigated SMARCAD1 level in <italic>Topbp1</italic> MO in 2-cell and 4-cell arrested embryos. We observed a severe reduction of SMARCAD1 that was even more pronounced when analyzing the pool of 2-cell arrested embryos (Fig <xref rid="fig4" ref-type="fig">4E</xref>-<xref rid="fig4" ref-type="fig">4H</xref> and <xref rid="figs5" ref-type="fig">S5J-S5L</xref>).</p>
<p>Collectively, these results confirm the functional interaction between SMARCAD1 and TOPBP1showing that <italic>Smarcad1</italic> or <italic>Topbp1</italic> knockdown impair mouse embryo development and that their role in the maintenance of H3K9me3 heterochromatin foci might contribute to the developmental arrest. Overall, our results suggest that both SMARCAD1 and TOPBP1 contribute to proper early embryo development.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>Heterochromatin formation during early embryogenesis is a fundamental aspect of development (<italic><xref ref-type="bibr" rid="c4">4</xref></italic>). Here, we have reported that the transition from the 2C-like to the pluripotent state is a robust <italic>in vitro</italic> model system to study heterochromatin foci establishment and their reorganization in early embryo development. During the 2C-like to pluripotency transition, we found that heterochromatin foci are re-formed along with the DNA compaction of the chromatin fibers. Unlike previous reports that focused exclusively on transcriptional changes (<italic><xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c14">14</xref>, <xref ref-type="bibr" rid="c41">41</xref></italic>), our study exploited chromatin proteomics by genome capture to unravel an additional layer of information and complexity in the 2C-like system. Thus, we provided a detailed characterization of the stepwise chromatome dynamics occurring during the 2C-like state transition. Remarkably, we identified the chromatin remodeler factor SMARCAD1 and TOPBP1, a binding protein interacting with topoisomerase to contribute to embryo development. Depletion of SMARCAD1 or TOPBP1 in preimplantation embryos led to severe developmental arrest and to a substantial remodeling of H3K9me3 heterochromatin foci. These findings have important implications because the establishment and maintenance of heterochromatin foci during embryo development is a key step in the embryonic totipotent program of the 2-cell stage toward pluripotency (<italic><xref ref-type="bibr" rid="c1">1</xref>, <xref ref-type="bibr" rid="c42">42</xref></italic>).</p>
<p>Endogenous retroviruses (ERVs) are transposable elements flanked by long terminal direct repeats (LTRs) (<italic><xref ref-type="bibr" rid="c43">43</xref>, <xref ref-type="bibr" rid="c44">44</xref></italic>). Tight control of ERVs and their transposable activity is essential for genome integrity and play an important role in early development and pluripotency (<italic><xref ref-type="bibr" rid="c43">43</xref>, <xref ref-type="bibr" rid="c44">44</xref></italic>). H3K9me3 has been associated with retrotransposons through the KRAB-associated protein 1, KAP1 (<italic><xref ref-type="bibr" rid="c45">45</xref></italic>). KAP1 led to the silencing of ERVs in ESCs by inducing H3K9me3 heterochromatin formation via the recruitment of the H3K9 histone methyltransferase SETDB1 (<italic><xref ref-type="bibr" rid="c45">45</xref>-<xref ref-type="bibr" rid="c47">47</xref></italic>). SMARCAD1 was discovered recently to directly interact with KAP1 and therefore be an important regulator of the KAP1-SETDB1 silencing complex in ESCs (<italic><xref ref-type="bibr" rid="c36">36</xref>, <xref ref-type="bibr" rid="c48">48</xref></italic>). SMARCAD1 is also a key factor for ERV silencing in ESCs (<italic><xref ref-type="bibr" rid="c36">36</xref></italic>), where it remodels nucleosomes (<italic><xref ref-type="bibr" rid="c49">49</xref></italic>). Of note, although SMARCAD1 is highly expressed in ESCs, its depletion does not affect pluripotency (<italic><xref ref-type="bibr" rid="c36">36</xref>, <xref ref-type="bibr" rid="c49">49</xref>, <xref ref-type="bibr" rid="c50">50</xref></italic>).</p>
<p>SMARCAD1 has been described in ESCs, yet its function in 2C-like cells has not been explored. Our observation that SMARCAD1 enriches in H3K9me3 heterochromatin foci during the transition from the 2C-like state to pluripotency and that it contributes to early mouse embryo development is aligned with the observations previously reported in ESCs. It will be interesting in the future to study whether SMARCAD1 can tether the KAP1-SETDB1 to directly induce the formation of H3K9me3 heterochromatin foci at the exit of the 2-cell stage in the embryos. Recently, the H3K9 histone methyltransferase SUV39H2 has been reported to catalyze <italic>de novo</italic> H3K9me3 in the paternal pronucleus after fertilization (<italic><xref ref-type="bibr" rid="c51">51</xref></italic>). Yet, <italic>Suv39h2</italic> downregulation in zygote-stage embryos did not translate on appreciable changes in H3K9me3 levels on the maternal chromatin. This opens up the possibility that different methyltransferases, and their regulators like SMARCAD1, could be responsible for H3K9me3 acquisition in this early developmental stage.</p>
<p>Topoisomerases likely cooperate with the chromatin remodeling factor SMARCAD1 in yeast (<italic><xref ref-type="bibr" rid="c27">27</xref></italic>). We observed that SMARCAD1 and TOPBP1 both interact with H3K9me3 suggesting they might work as a complex, this result is also confirmed by the observed reduction of SMARCAD1 in heterochromatin foci in both <italic>Topbp1</italic>-depleted cells and <italic>Topbp1</italic>-depleted embryos. We showed that topoisomerase inhibition led to an increase in the fraction of 2C-like cells and cell cycle arrest in the G2/M phase. Moreover, the knock-down of TOPBP1 leads to a severe developmental arrest. Thus, it is also tempting to speculate that cell cycle progression, especially since we observed that 2C<sup>+</sup> cells might be arrested in the G2/M phase, has a role in regulating SMARCAD1 recruitment and/or function on chromatin during the 2C<sup>+</sup> exit. In the <italic>in vivo</italic> scenario, this prolonged G2/M phase might be necessary to rewire specific epigenetic modifications in the 2-cell blastomeres to allow heterochromatin formation. TOPBP1, being a DNA topoisomerase 2-binding protein, might have a role in this process. This is a key step before the blastomeres can embark into the correct developmental process, as proposed for early Drosophila embryos (<italic><xref ref-type="bibr" rid="c52">52</xref></italic>).</p>
<p>By using chromatin proteomics, we have provided additional data that will help to elucidate the molecular intricacies of the 2C-like state and early mammalian development. In the current study, we focused on heterochromatin establishment and we identified SMARCAD1 and TOPBP1, which both interact with H3K9me3. SMARCAD1 might act in the complex as the remodeler factor that, by regulating methyltransferases, can facilitate H3K9me3 deposition at the exit of the totipotent 2-cell stage when heterochromatin is established <italic>de novo</italic>. Although we could not collect robust data on the alteration of the 2C program, we have indication of its prolonged activity when either SMARCAD1 or TOPBP1 are knocked down, in line with a role in regulating early development in the maintenance of heterochromatin and the regulation of the 2C program.</p>
</sec>
<sec id="s4">
<title>Materials and Methods</title>
<sec id="s4a">
<title>Cell lines and culture conditions</title>
<p>E14Tg2a mouse ESCs were cultured in gelatinized plates in high glucose DMEM supplemented with 15 % FBS (Sigma), GlutaMAX, sodium pyruvate, non-essential amino acids, penicillin/streptomycin, 100 µM 2-mercaptoethanol, 1000 U/ml mouse leukemia inhibitory factor (mLIF) (Millipore), 1 µM PD0325901 and 3 µM CHIR99021. After viral infection, ESCs were selected and maintained with ES medium containing the appropriate combination of selection drugs (250 µg/ml Geneticin (G418, Life Technologies), 0.5 µg/ml Puromycin (Life Technologies)). ESCs were treated with 2 µg/ml doxycycline (D9891, Sigma) for 24 h to induce Dux expression.</p>
</sec>
<sec id="s4b">
<title>Lentivirus production and ESC infection</title>
<p>Lentiviral particles were produced following the RNA interference Consortium (TRC) instructions for viral production and cell infection (<ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/rnai/public/">http://www.broadinstitute.org/rnai/public/</ext-link>). HEK293T cells were co-transfected with the lentiviral plasmid of interest (pCW57.1-Luciferase or pCW57.1-mDux-CA) and the viral packing vectors (pCMV-ΔR8.9 and pCMV-VSV-G) using the CalPhos mammalian transfection kit (631312, Clontech). pCW57.1-Luciferase and pCW57.1-mDux-CA were a gift from Stephen Tapscott (Addgene plasmids #99283 and #99284). Short hairpins targeting <italic>Smarcad1</italic> (shSmarcad1), <italic>Topbp1</italic> (shTopbp1 #1 and shTopbp1 #2) and a scramble control sequence (shScbl) were cloned into the pLKO.1-Hygro lentiviral vector (Addgene plasmid #24150). The lentiviral-containing medium was harvested from HEK293T cells at 48 h and 72 h after transfection, filtered and used for ESC infection. Two days after the last round of infection, ESCs were selected with the indicated concentration of the selection drug (see Cell culture).</p>
</sec>
<sec id="s4c">
<title>Fluorescence-activated cell sorting (FACS)</title>
<p>Quantification of GFP positive cells and cell cycle analysis was performed with a LSR II Analyzer (BD Biosciences). For cell sorting, an Influx Cell Sorter (BD Biosciences) was used to sort the specified populations in each experiment.</p>
</sec>
<sec id="s4d">
<title>Cell cycle analysis by flow cytometry</title>
<p>For cell cycle analysis of live cells, 5 ×10<sup>4</sup> ESCs were plated per well in gelatin-coated 6-well plates one day before starting the experiment. At the moment of the assay, ESCs were trypsinized, collected and washed with PBS before incubation with ES medium supplemented with 10 µg/ml Hoechst 33342 (H1399, Thermo Fisher) for 30 min at 37 °C. Propidium iodide (PI) (1 µg/ml; P4864, Sigma) was added to stain dead cells. All flow cytometry data were processed and analyzed with FlowJo (v10).</p>
</sec>
<sec id="s4e">
<title>Inhibition of DNA topoisomerases</title>
<p>To inhibit DNA topoisomerases, ESCs were treated with 500 nM of the topoisomerase I inhibitor camptothecin (CPT; ab120115, Abcam) and/or with 5 µM of the topoisomerase II inhibitor ICRF-193 (I4659, Sigma) for 12 h.</p>
</sec>
<sec id="s4f">
<title>Immunostaining, image processing and quantification</title>
<sec id="s4f1">
<title>Immunofluorescence staining of ESCs</title>
<p>ESCs were plated at a concentration of 56.000 cells/cm<sup>2</sup> in gelatin-coated borosilicate glass bottom Nunc Lab-Tek (155411, Thermo Fisher) or µ-Slide (80827, Ibidi) 8-well chambers. Cells were fixed with 4 % paraformaldehyde (PFA) for 10 min and were then washed three times with PBS. Cells were permeabilized and blocked (10 % GS, 2.5 % BSA, 0.4 % Triton X-100) for 30 min at room temperature (RT). Incubation with the corresponding primary antibodies at the indicated dilutions lasted 3 h at 37 °C. Cells were then washed and incubated with Alexa Fluor (Molecular Probes, Invitrogen) secondary antibodies for 1 h at RT. For H3K9me3 and SMARCAD1 co-staining, cells were washed three times with PBS after secondary antibody incubation. Then cells were incubated with second primary antibody and the corresponding secondary antibody as indicated above. Finally, cells were washed three times with PBS containing DAPI for nuclear counterstain. Images were acquired on a Leica TCS SP5 confocal microscope equipped with a 63x oil objective.</p>
<p>The following antibodies were used: chicken anti-GFP (1:500; ab13970, Abcam), mouse anti-Oct-3/4 (1:200; sc-5279, Santa Cruz), rabbit anti-histone H3K9me3 (1:500; ab8898, Abcam), mouse anti-SMARCAD1 (1:500; ab67548, Abcam), goat anti-chicken Alexa Fluor 488, goat anti-mouse Alexa Fluor 568, goat anti-rabbit Alexa Fluor 568, goat anti-mouse Alexa Fluor 647. All secondary antibodies were provided by Molecular Probes (Invitrogen).</p>
</sec>
<sec id="s4f2">
<title>EdC incorporation and DNA labelling</title>
<p>To label DNA, a 14 h incorporation pulse of 5-ethynyl-2’-deoxycytidine (EdC; T511307, Sigma) at 2.5 µM was performed in ESCs, in parallel to doxycycline treatment. Cells were plated in gelatin-coated borosilicate glass bottom chambers at a concentration of 56.000 cells/cm<sup>2</sup> in ES medium supplemented with EdC for 14 hours. At the end of EdC incorporation, ESCs were fixed with PFA 4 % (43368, Thermo Fisher Alfa Aesar) and permeabilized with 0.4 % Triton X-100. Click chemistry reaction was performed by incubating cells for 30 min at RT in click chemistry buffer: 100 mM Hepes pH 8.2, 50 mM Amino Guanidine (396494, Sigma), 25 mM Ascorbic Acid (A92902, Sigma), 1 mM CuSO<sub>4</sub>, 2 % Glucose (G8270, Sigma), 0.1 % Glox solution [0.5 mg/ml glucose oxidase, 40 mg/ml catalase (G2133 and C100, Sigma)] and 10 mM Alexa Fluor 647 Azide (A-10277, Thermo Fisher) (<italic><xref ref-type="bibr" rid="c31">31</xref>, <xref ref-type="bibr" rid="c32">32</xref>, <xref ref-type="bibr" rid="c53">53</xref></italic>). After washing the samples three times with PBS, we directly proceeded to perform STORM imaging.</p>
</sec>
<sec id="s4f3">
<title>STORM imaging</title>
<p>Stochastic Optical Reconstruction Microscopy (STORM) imaging was performed on a N-STORM 4.0 microscope (Nikon) equipped with a CFI HP Apochromat TIRF 100x 1.49 oil objective and a iXon Ultra 897 camera (Andor) with a pixel size of 16 µm. This objective/camera combination provides an effective pixel size of 160 nm. STORM images were acquired with 10 msec exposure time for 60000 frames using highly inclined (HILO) illumination. An activator/reporter pair strategy was used with AF405 and AF647 fluorophores, respectively. Continuous imaging acquisition was performed with simultaneous 405 nm and 647 nm illumination. 647 nm laser was used at constant ∼2 kW/cm<sup>2</sup> power density. 405 nm laser was used at low laser power and gradually increased during the imaging to enhance fluorophore reactivation and to maintain the density of localizations per frame constant. Before STORM imaging, we acquired conventional fluorescence images of GFP for each nucleus to discriminate between 2C<sup>−</sup> and 2C<sup>+</sup> cells. Imaging buffer composition for STORM imaging was 100 mM Cysteamine MEA (30070, Sigma), 1 % Glox Solution and 5 % Glucose (G8270, Sigma) in PBS.</p>
<p>STORM images were analyzed and rendered in Insight3 as previously described (<italic><xref ref-type="bibr" rid="c54">54</xref>, <xref ref-type="bibr" rid="c55">55</xref></italic>). Localizations were identified based on an intensity threshold and the intensity distribution of their corresponding Point Spread Functions (PSFs) fit with a 2D Gaussian to determine the x-y positions of their centers with high accuracy (∼20 nm).</p>
</sec>
<sec id="s4f4">
<title>Voronoi Tesselation analysis</title>
<p>For Voronoi Tesselation analysis, we used the list of localization from STORM (<italic><xref ref-type="bibr" rid="c33">33</xref>, <xref ref-type="bibr" rid="c34">34</xref></italic>) and then we used a previously developed custom-made Matlab script (<italic><xref ref-type="bibr" rid="c31">31</xref></italic>). X-y coordinates of the localizations were used to generate the Voronoi polygons. Local densities were defined as the inverse value of the area of each Voronoi polygon. For visualization, we color-coded each Voronoi polygon based on their area, from yellow for the smallest polygons (density &gt; 0.01 nm<sup>−2</sup>), to blue for larger polygons (density &lt; 0.0001 nm<sup>−2</sup>). Finally, the largest 0.5 % of polygons were set to black. For each nucleus, we computed the mean Voronoi density (nm<sup>−2</sup>) as a measure of global DNA compaction.</p>
<p>For the GFP intensity score, we quantified the GFP conventional images (488 nm channel) with lower intensities in order to assign a GFP intensity score to each nucleus. We summed the fluorescence intensity ADU counts inside each nucleus and divided it by the total number of pixels to obtain the average GFP intensity. Then, we used the distribution of GFP intensities from the different nuclei to normalize the values, obtaining a GFP intensity score ranging from 0 (less bright) to 1 (most bright). We then performed a cell-by-cell analysis of the relation between GFP intensity score and global chromatin compaction obtained from Voronoi Tesselation analysis.</p>
</sec>
<sec id="s4f5">
<title>Immunofluorescence of preimplantation embryos</title>
<p>Preimplantation embryos at E1.5 and E2.5 stages were fixed with 2 % PFA for 10 min at RT, permeabilized (0.25 % Triton X-100) for 10 min, and then blocked (3 % BSA) for 1 h at 37 °C. Incubation with the corresponding primary antibodies at the indicated dilutions in 1 % BSA lasted one overnight at 4 °C. After washing, embryos were incubated with Alexa Fluor (Molecular Probes, Invitrogen) secondary antibodies diluted in 1 % BSA for 1 h at 37 °C. Finally, embryos were washed and transferred to an imaging buffer containing DR (1:500; 62251, Thermo Fisher) for DNA staining. Images were acquired on a Leica TCS SP8 STED3X confocal microscope equipped with a 63x oil objective.</p>
<p>The following antibodies were used: rabbit anti-histone H3K9me3 (1:500; ab8898, Abcam), mouse anti-SMARCAD1 (1:250; ab67548, Abcam), rabbit anti-HP1β (1:200; ab10478, Abcam), goat anti-rabbit Alexa Fluor 488 and goat anti-mouse Alexa Fluor 488. All secondary antibodies were provided by Molecular Probes (Invitrogen).</p>
</sec>
<sec id="s4f6">
<title>Image processing and quantification</title>
<p>Immunofluorescence images were processed and analyzed with the ImageJ software (<ext-link ext-link-type="uri" xlink:href="https://imagej.net/download/">https://imagej.net/download/</ext-link>). All immunofluorescence images were acquired with z-stacks. Z-stacks were projected using the <italic>maximum intensity</italic> z-projection type. For SMARCAD1 nuclear signal analysis, manual selection of nuclear area was performed and integrated intensity was measured. For SMARCAD1-H3K9me3 co-immunofluorescence images, a Gaussian blur filtering (σ = 0.5) was applied to the SMARCAD1 channel. Fluorescence intensities of H3K9me3 foci were analyzed using the <italic>3D Object Counter</italic> function (<ext-link ext-link-type="uri" xlink:href="https://imagej.net/3D_Objects_Counter">https://imagej.net/3D_Objects_Counter</ext-link>, ImageJ). Co-localization analysis was done using the <italic>JACoP</italic> plugin (<ext-link ext-link-type="uri" xlink:href="https://imagej.net/JaCoP">https://imagej.net/JaCoP</ext-link>, ImageJ). Manders’ coefficient was calculated with the <italic>JACoP</italic> plugin. Manders’ coefficient was used as a co-localization indicator because of its independence of the intensity of the overlapping pixels. For the quantification of H3K9me3 and SMARCAD1 fluorescence intensities in preimplantation embryos, manual selection of the nuclear area was performed for each blastomere. Fluorescent signals were measured and then normalized by the average cytoplasmic signal (background) in each condition. For the normalization step, the fluorescence intensity of a squared shape of equal size was taken for each individual blastomere.</p>
</sec>
<sec id="s4f7">
<title>RNA extraction and quantitative real-time PCR (qRT-PCR)</title>
<p>RNA was extracted from pelleted or sorted ESCs using the RNA isolation RNeasy Mini kit (QIAGEN), according to the manufacturer protocol. RNA was reverse-transcribed with iScript cDNA Synthesis kit (Bio-Rad). qRT-PCR reactions were performed using LightCycler 480 SYBR Green I Master (Roche) in a LightCycler 480 (Roche) instrument, according to the manufacturer recommendations. The oligos used are listed in <xref rid="tbl1" ref-type="table">Table 1</xref>. qRT-PCR data was normalized to <italic>Gapdh</italic> or <italic>β-actin</italic> expression. For each sample, we had at least a technical duplicate.</p>
</sec>
<sec id="s4f8">
<title>Chromatin-bound proteome profiling by genome capture (iPOTD)</title>
<p>ESCs were plated at a concentration of 34.000 cells/cm<sup>2</sup> in gelatin-coated 150-mm dishes. Then, ESCs were pulsed for 24 h with 0.1 µM 5-ethynyl-2’-deoxyuridine (EdU; T511285, Sigma), in parallel to doxycycline treatment. Sorted luciferase (± EdU), 2C<sup>−</sup> +EdU and 2C<sup>+</sup> +EdU cells were fixed with 1 % PFA, quenched with 0.125 mM glycine (pH 7) and harvested immediately after sorting. Of note, ∼ 10<sup>7</sup> cells were sorted per replicate and condition. Cells were later processed as described previously to extract the chromatin-bound proteins (<italic><xref ref-type="bibr" rid="c16">16</xref>, <xref ref-type="bibr" rid="c17">17</xref></italic>).</p>
</sec>
</sec>
<sec id="s4g">
<title>Mass spectrometry analysis</title>
<sec id="s4g1">
<title>Sample preparation</title>
<p>Eluted proteins were reduced with dithiothreitol (37 °C, 60 min) and alkylated in the dark with iodoacetamide (25 °C, 20 min) prior to sequential digestion with endoproteinase LysC (1:10 w:w, 37 °C, overnight; 129-02541, Wako) and trypsin (1:10 w:w, 37 °C, 8 h) according to filter-aided sample preparation procedure (<italic><xref ref-type="bibr" rid="c56">56</xref></italic>). After digestion, the peptide mixtures were acidified with formic acid and desalted with a MicroSpin C18 column (The Nest Group, Inc) prior to LC-MS/MS analysis.</p>
</sec>
<sec id="s4g2">
<title>Chromatographic and mass spectrometric analysis</title>
<p>Samples were analyzed using a LTQ-Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA) coupled to an EASY-nLC 1200 (Thermo Fisher Scientific (Proxeon), Odense, Denmark). Peptides were loaded directly onto the analytical column and were separated by reversed-phase chromatography using a 50-cm column with an inner diameter of 75 μm, packed with 2 μm C18 particles spectrometer (Thermo Scientific, San Jose, CA, USA).</p>
<p>Chromatographic gradients started at 95 % buffer A and 5 % buffer B with a flow rate of 300 nl/min for 5 minutes and gradually increased to 22 % buffer B and 78 % A in 79 min and then to 35 % buffer B and 65 % A in 11 min. After each analysis, the column was washed for 10 min with 10 % buffer A and 90 % buffer B. Buffer A was 0.1 % formic acid in water and buffer B was 0.1 % formic acid in acetonitrile.</p>
<p>The mass spectrometer was operated in positive ionization mode with nanospray voltage set at 1.9 kV and source temperature at 275 °C. Ultramark 1621 was used for external calibration of the FT mass analyzer prior the analyses, and an internal calibration was performed using the background polysiloxane ion signal at m/z 445.1200. The acquisition was performed in data-dependent acquisition (DDA) mode and full MS scans with 1 micro scans at resolution of 120,000 were used over a mass range of m/z 350-1500 with detection in the Orbitrap mass analyzer. Auto gain control (AGC) was set to 1E5 and charge state filtering disqualifying singly charged peptides was activated. In each cycle of data-dependent acquisition analysis, following each survey scan, the most intense ions above a threshold ion count of 10000 were selected for fragmentation. The number of selected precursor ions for fragmentation was determined by the “Top Speed” acquisition algorithm and a dynamic exclusion of 60 seconds. Fragment ion spectra were produced via high-energy collision dissociation (HCD) at normalized collision energy of 28 % and they were acquired in the ion trap mass analyzer. AGC was set to 1E4, and an isolation window of 1.6 m/z and maximum injection time of 200 ms were used. All data were acquired with Xcalibur software.</p>
<p>Digested bovine serum albumin (P8108S, NEB) was analyzed between each sample to avoid sample carryover and to assure stability of the instrument and QCloud has been used to control instrument longitudinal performance during the project (<italic><xref ref-type="bibr" rid="c57">57</xref></italic>).</p>
</sec>
<sec id="s4g3">
<title>Data analysis</title>
<p>Acquired spectra were analyzed using the Proteome Discoverer software suite (v2.3, Thermo Fisher Scientific) and the Mascot search engine (<italic><xref ref-type="bibr" rid="c58">58</xref></italic>) (v2.6, Matrix Science). The data were searched against a Swiss-Prot mouse database (as in October 2019) plus a list of common contaminants and all the corresponding decoy entries (<italic><xref ref-type="bibr" rid="c22">22</xref></italic>). For peptide identification a precursor ion mass tolerance of 7 ppm was used for MS1 level, trypsin was chosen as enzyme, and up to three missed cleavages were allowed. The fragment ion mass tolerance was set to 0.5 Da for MS2 spectra. Oxidation of methionine and N-terminal protein acetylation were used as variable modifications whereas carbamidomethylation on cysteines was set as a fixed modification. False discovery rate (FDR) in peptide identification was set to a maximum of 5 %. The analysis of specific chromatin interactors was carried out with SAINT (v2, Significance Analysis of INTeractome) as previously described (<italic><xref ref-type="bibr" rid="c22">22</xref>, <xref ref-type="bibr" rid="c58">58</xref></italic>). Replicate 2 of the 2C<sup>+</sup> condition was excluded for SAINT analysis due to abnormal lower peptide-spectrum matches (PSM) observed in this run. Hierarchical clustering of all the chromatome replicates was computed and visualized using Instant Clue (<italic><xref ref-type="bibr" rid="c59">59</xref></italic>) v0.5.2 (<ext-link ext-link-type="uri" xlink:href="https://www.instantclue.uni-koeln.de/">https://www.instantclue.uni-koeln.de/</ext-link>). Pearson’s correlation coefficients were calculated using the Prism software (v9.0, GraphPad, San Diego, CA). To identify proteins shared by the 2C<sup>−</sup> and Luc chromatomes and not enriched in the 2C<sup>+</sup> chromatome, an average enrichment value was computed from the respective pairwise comparisons (i.e., Luc vs 2C<sup>−</sup>; Luc vs 2C<sup>+</sup>; 2C<sup>−</sup> vs Luc; 2C<sup>−</sup> vs 2C<sup>+</sup>) and then selecting those hits that were more commonly enriched among the 2C<sup>−</sup> and Luc chromatomes (FC ≥ 2). Gene ontology (GO) term enrichment was performed with GO Enrichment Analysis using the PANTHER tool (<italic><xref ref-type="bibr" rid="c60">60</xref>, <xref ref-type="bibr" rid="c61">61</xref></italic>) (<ext-link ext-link-type="uri" xlink:href="https://geneontology.org/">https://geneontology.org/</ext-link>). Protein interaction data were retrieved from the STRING database v11.0 (<italic><xref ref-type="bibr" rid="c62">62</xref></italic>) and visualized with Cytoscape v3.8.2 (<italic><xref ref-type="bibr" rid="c63">63</xref></italic>).</p>
</sec>
<sec id="s4g4">
<title>Western blot (WB) analysis</title>
<p>Protein extracts were boiled in Laemmli buffer, run in precast protein gel (Mini-PROTEAN TGX; 4561084, Bio-Rad) and then transferred to immuo-blot polyvinylidene difluoride membranes (162-0177, Bio-Rad). The membranes were blocked and incubated with the indicated primary antibodies overnight at 4 °C [rabbit anti-histone H3K9me3 (1:500; ab8898, Abcam), mouse anti-OCT4 (1:500; sc-5279, Santa Cruz), rabbit anti-TOPBP1 (1:1000; ab2402, Abcam) and mouse anti-SMARCAD1 (1:500; ab67548, Abcam)].</p>
<p>After washing, membranes were incubated with specific peroxidase-conjugated secondary antibodies [sheep anti-mouse IgG HRP-linked (1:1000; NA931, GE Healthcare) and donkey anti-rabbit IgG HRP-linked (1:2000; NA934, GE Healthcare)] and visualized on an Amersham Imager 600 (29083461, GE Healthcare Life Sciences).</p>
</sec>
<sec id="s4g5">
<title>Dot blot analysis</title>
<p>Samples were spotted in triplicates in 1 µl dots onto a nitrocellulose membrane (0.2 µM, Amersham Protan), air-dried, and detected following standard blotting procedures with the corresponding antibodies (rabbit anti-histone H3 (1:1000; ab1791, Abcam), mouse anti-vinculin (1:1000; V9131, Merck)). Quantification of dot blots was performed by Image Studio Lite software (v5.2, LI-COR, Biosciences). For quantification, each protein was normalized to its background signal.</p>
</sec>
<sec id="s4g6">
<title>Co-immunoprecipitation (co-IP)</title>
<p>ESCs were washed with PBS, trypsinized and pelleted. Freshly collected pellets were used for co-IP experiments. ESCs were lysed for 10 min at 4 °C (10 mM tris-HCl (pH 7.4), 10 mM KCl, 15 mM MgCl<sub>2</sub>) in the presence of Protease Inhibitor Cocktail (PIC; 5056489001, Roche). Nuclei were pelleted and lysed for 1 h at 4 °C (300 mM NaCl, 50 mM Hepes (pH 7.5), 0.5 % NP-40, 2.5 mM MgCl<sub>2</sub>) in the presence of benzonase endonuclease (100 U/ml; 71205, Novagen). Benzonase removes DNA and RNA, thereby releasing DNA-binding proteins. After nuclear lysis, samples were pelleted and supernatants containing protein extracts were harvested. Protein concentrations were determined using the Pierce BCA protein assay (23225, Thermo Fisher) according to the manufacturer’s protocol. For endogenous IPs, an aliquot of protein extract (0.8-1 mg) diluted in dilution buffer (300 mM NaCl, 50 mM Hepes (pH 7.5), 0.5 % NP-40, 5 mM EDTA + PIC) was incubated with 25 μl of pre-washed Dynabeads Protein G (10004D, Thermo Fisher) and with 4 µg of the antibody of interest overnight at 4 °C. For mock IP, ChromPure Mouse (015-000-003, Jackson Immunoresearch) or Rabbit (011-000-003, Jackson Immunoresearch) IgGs were used. Samples were then washed three times. Elution was performed by incubating the dried beads with 30 μl of 2x Laemmli buffer (1610747, Bio-Rad) supplemented with 50 mM of 2-mercaptoethanol for 10 min at 95 °C. After eluting the samples, we directly proceeded to perform western blotting.</p>
<p>The following antibodies were used: rabbit anti-histone H3K9me3 (ab8898, Abcam) and rabbit anti-TOPBP1 (ab2402, Abcam).</p>
</sec>
<sec id="s4g7">
<title>CRISPR-Cas9 plasmid generation and delivery</title>
<p>Single guide RNAs (sgRNAs) targeting each of the specific target genes were retrieved from the Mouse CRISPR Knockout Pooled Library (Addgene #73632). Two sgRNA sequences were selected per gene of interest (for sgRNAs sequences, see <xref rid="tbl2" ref-type="table">Table 2</xref>). The sgRNAs with the highest on-target activity score (Rule Set 2) were selected for assembly into the CRISPR-Cas9 vector. An sgRNA targeting the luciferase sequence was also included as control. Primers containing sequences for the sgRNAs were annealed in the presence of T4 ligation buffer (Thermo Fisher) and T4 PNK (NEB) in a heat block (30 °C for 30 min, 95 °C for 5 min and slow cool down to RT). Annealed primers were then cloned into the pU6-(BbsI)_CBh-Cas9-T2A-mCherry plasmid following a one-step cloning reaction. pU6-(BbsI)_CBh-Cas9-T2A-mCherry was a gift from Ralf Kuehn (Addgene plasmid #64324).</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2</label>
<caption><p>– List of oligos used for qRT-PCR</p></caption>
<graphic xlink:href="537018v1_tbl2.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<table-wrap id="tbl3" orientation="portrait" position="float">
<label>Table 3</label>
<caption><p>– List of top oligos used for cloning sgRNAs</p></caption>
<graphic xlink:href="537018v1_tbl3.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<p>To generate CRISPR-Cas9-targeted ESCs, cells were nucleofected with 4 µg of the sgRNA-containing plasmid individually following the Amaxa Mouse ES cell Nucleofector kit recommendations (VPH-1001, Lonza). Later, ESCs were FACS-sorted 48 h after nucleofection to enrich for the modified cells.</p>
</sec>
<sec id="s4g8">
<title>Zygote collection and culture</title>
<p>Embryos were collected at E0.5 from 6 to 10 weeks BDF1 female mice (Charles River Laboratories) following 5 IU pregnant mare’s serum gonadotrophin (PMSG) and 5 IU human chorionic gonadotropin (hCG) injections at 48 hours intervals. Female mice were mated with BDF1 male mice immediately after hCG injection. Embryos were collected from the oviducts 24 hours post-hCG and were briefly cultured in M2 medium supplemented with 0.2 mg/ml hyaluronidase (H3506, Sigma) to remove cumulus cells. Cumulus-free embryos were washed and cultured with Advanced KSOM medium (MR-101-D, Millipore) at 37 °C until microinjection.</p>
</sec>
<sec id="s4g9">
<title>Microinjection of morpholino antisense oligos</title>
<p>Morpholino antisense oligos (MO) for <italic>Smarcad1</italic> and <italic>Topbp1</italic> and non-targeting control were designed and produced by Gene Tools (Gene Tools, LLC). MOs were microinjected into the cytoplasm of E0.5 embryos using a Narishige micromanipulator system mounted on an Olympus IX71 inverted microscope. Embryos were immobilized using a holding pipette and MOs were then microinjected using a Narishige pneumatic microinjector (IM-300, Narishige). After microinjection, embryos were cultured in Advanced KSOM medium in low oxygen conditions (5 % CO<sub>2</sub>, 5 % O<sub>2</sub>) at 37 °C for 5 days (until E5.5). Preimplantation development was examined every 24 hours using an AMG EVOS microscope.</p>
<p>The following MO sequences were used:</p>
<p>Control MO: TCCAGGTCCCCCGCATCCCGGATCC;</p>
<p><italic>Smarcad1</italic> MO: ATATTGGGAGGAACCACCACCCTGA;</p>
<p><italic>Topbp1</italic> MO: ACGGCTCTTGGTCATTTCTGGACAT;</p>
<p>All morpholino sequences are written from 5’ to 3’ and they are complementary to the translation-blocking target.</p>
<p>All animal experiments were approved and performed in accordance with institutional guidelines [Parc de Recerca Biomèdica de Barcelona (PRBB), Barcelona, Spain] and in accordance with the Ethical Committee for Animal Experimentation (CEEA) number PC-17-0019-PI, approved by La Comissió d’Experimentació Animal, Departament de Territori i Sostenibilitat, Direcció General de Polítiques Ambientals i Medi Natural, Generalitat de Catalunya.</p>
</sec>
<sec id="s4g10">
<title>Statistical analysis</title>
<p>As specified in the figure legends, data are presented either as scatter dot plots with line at mean ± SD or at median ± interquartile range, bar graphs showing mean ± SD, min to max boxplots with line at median, or as violin plots showing median and quartiles. All statistical tests and graphs were generated using the Prism software (v9.0, GraphPad, San Diego, CA), unless otherwise indicated. Depending on the experimental setup, we used unpaired two-tailed Student’s <italic>t</italic>-test, multiple <italic>t</italic>-test, Fisher’s exact test, Mann-Whitney test, one-way ANOVA or two-way ANOVA with the indicated post-comparison test. In all cases, a <italic>P</italic> value p ≤ 0.05 was considered significant (p ≤ 0.05*; p ≤ 0.01**; p ≤ 0.001***; p ≤ 0.0001****; p &gt; 0.05<sup>ns</sup>, not significant).</p>
</sec>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We would like to thank M.-E. Torres-Padilla (Helmholtz Zentrum München), B.R. Cairns (Huntsman Cancer Institute) and B. Huang (UCSF) for sharing E14 ESCs containing the 2C::EGFP reporter, an independent E14 ESC clone containing the Dux-CA cassette and Insight3 software. We are grateful to S. Sdelci for critical reading of the manuscript. We also thank the CRG/UPF Flow Cytometry Unit, the CRG Advanced Light Microscopy Unit, and the PRBB animal facility (PRBB, Barcelona).</p>
</ack>
<sec id="s5">
<title>Funding</title>
<p>This work was supported by the European Union’s Horizon 2020 Research and Innovation Programme (CellViewer No 686637 to M.P.C.); Ministerio de Ciencia e Innovación, grant BFU2017-86760-P (AEI/FEDER, UE); and an AGAUR grant from Secretaria d’Universitats i Recerca del Departament d’Empresa I Coneixement de la Generalitat de Catalunya (2017 SGR 689 to M.P.C.); National Natural Science Foundation of China (No 31971177 to M.P.C.); Spanish Ministry of Economy, Industry and Competitiveness (MEIC) (PID2019-108322GB-100 to L.D.C.), and from AGAUR (L.D.C.). We acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme. The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I+D+i 2013-2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF. R.S.-P. was supported by a FI-AGAUR PhD fellowship from the Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya and the co-finance of Fondo Social Europeo (2018FI_B_00637 and FSE). X.T. is supported by a FPI PhD fellowship from the Ministerio de Ciencia e Innovación (PRE2018-085107). S.A. is funded by the Ramon y Cajal program of the Ministerio de Ciencia, Innovación y Universidades and the European Social Fund under the reference number RYC-2018-025002-I, and the Instituto de Salud Carlos III-FEDER (PI19/01814). L.M. is supported by a grant for the recruitment of early-stage research staff FI-2020 (Operational Program of Catalonia 2014-2020 CCI grant no. 2014ES05SFOP007 of the European Social Fund) and La Caixa Foundation fellowship (LCF/BQ/DR20/11790016). M.P. was supported by a Severo Ochoa PhD fellowship from the Subprograma Estatal de Formación del Ministerio de Economía y Competitividad (BES-2015-072802). M.V.N. is funded by FP7/2007–2013 under an REA grant (608959) and Juan de la Cierva-Incorporación 2017.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>R.S.-P. and M.P.C. conceptualized this work. R.S.-P. designed and performed most of the experiments with contributions from S.N., X.T., S.A., M.P., M.A.-B., J.L.G.-V, E.B., M.N.-R. Data were primarily analyzed by R.S.-P. with contributions from S.N., X.T., S.A., P.A.G.-G., D.C., E.B., E.S., L.M., M.N.-R., E.M. R.S.-P. and M.P.C. wrote the manuscript with input from S.N., X.T., M.V.N., S.A. and L.D.C. M.P.C., M.V.N., and L.D.C. supervised the project.</p>
</sec>
<sec id="s7">
<title>Competing interests</title>
<p>Authors declare that they have no competing interests.</p>
</sec>
<sec id="s8">
<title>Data and materials availability</title>
<p>The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (<ext-link ext-link-type="uri" xlink:href="http://proteomecentral.proteomexchange.org">http://proteomecentral.proteomexchange.org</ext-link>) via the PRIDE (<italic><xref ref-type="bibr" rid="c64">64</xref></italic>) partner repository with the dataset identifier PXD019703. All other data needed to evaluate the conclusions in this study are present in the paper and/or the Supplementary Materials. Additional materials generated in this study are available from the corresponding author upon request.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><given-names>A.</given-names> <surname>Burton</surname></string-name>, <string-name><given-names>M. E.</given-names> <surname>Torres-Padilla</surname></string-name>, <article-title>Chromatin dynamics in the regulation of cell fate allocation during early embryogenesis</article-title>. <source>Nat Rev Mol Cell Biol</source> <volume>15</volume>, <fpage>723</fpage>–<lpage>734</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><given-names>J.</given-names> <surname>Nakayama</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Rice</surname></string-name>, <string-name><given-names>B. D.</given-names> <surname>Strahl</surname></string-name>, <string-name><given-names>C. D.</given-names> <surname>Allis</surname></string-name>, <string-name><given-names>S. I.</given-names> <surname>Grewal</surname></string-name>, <article-title>Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly</article-title>. <source>Science</source> <volume>292</volume>, <fpage>110</fpage>–<lpage>113</lpage> (<year>2001</year>).</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><given-names>A. H.</given-names> <surname>Peters</surname></string-name>, <string-name><given-names>D.</given-names> <surname>O’Carroll</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Scherthan</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Mechtler</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Sauer</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Schofer</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Weipoltshammer</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Pagani</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Lachner</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Kohlmaier</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Opravil</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Doyle</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Sibilia</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Jenuwein</surname></string-name>, <article-title>Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability</article-title>. <source>Cell</source> <volume>107</volume>, <fpage>323</fpage>–<lpage>337</lpage> (<year>2001</year>).</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><given-names>A. V.</given-names> <surname>Probst</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Almouzni</surname></string-name>, <article-title>Heterochromatin establishment in the context of genome-wide epigenetic reprogramming</article-title>. <source>Trends Genet</source> <volume>27</volume>, <fpage>177</fpage>–<lpage>185</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><given-names>K. W.</given-names> <surname>Jones</surname></string-name>, <article-title>Chromosomal and nuclear location of mouse satellite DNA in individual cells</article-title>. <source>Nature</source> <volume>225</volume>, <fpage>912</fpage>–<lpage>915</lpage> (<year>1970</year>).</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><given-names>T. S.</given-names> <surname>Macfarlan</surname></string-name>, <string-name><given-names>W. D.</given-names> <surname>Gifford</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Driscoll</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Lettieri</surname></string-name>, <string-name><given-names>H. M.</given-names> <surname>Rowe</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Bonanomi</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Firth</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Singer</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Trono</surname></string-name>, <string-name><given-names>S. L.</given-names> <surname>Pfaff</surname></string-name>, <article-title>Embryonic stem cell potency fluctuates with endogenous retrovirus activity</article-title>. <source>Nature</source> <volume>487</volume>, <fpage>57</fpage>–<lpage>63</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><given-names>T.</given-names> <surname>Ishiuchi</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Enriquez-Gasca</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Mizutani</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Boskovic</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Ziegler-Birling</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Rodriguez-Terrones</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Wakayama</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Vaquerizas</surname></string-name>, <string-name><given-names>M. E.</given-names> <surname>Torres-Padilla</surname></string-name>, <article-title>Early embryonic-like cells are induced by downregulating replication-dependent chromatin assembly</article-title>. <source>Nat Struct Mol Biol</source> <volume>22</volume>, <fpage>662</fpage>–<lpage>671</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><given-names>Z.</given-names> <surname>Hu</surname></string-name>, <string-name><given-names>D. E. K.</given-names> <surname>Tan</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Chia</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Tan</surname></string-name>, <string-name><given-names>H. F.</given-names> <surname>Leong</surname></string-name>, <string-name><given-names>B. J.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>M. S.</given-names> <surname>Lau</surname></string-name>, <string-name><given-names>K. Y. S.</given-names> <surname>Tan</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Bi</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Yang</surname></string-name>, <string-name><given-names>Y. S.</given-names> <surname>Ho</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Bao</surname></string-name>, <string-name><given-names>E. S. M.</given-names> <surname>Wong</surname></string-name>, <string-name><given-names>W. W.</given-names> <surname>Tee</surname></string-name>, <article-title>Maternal factor NELFA drives a 2C-like state in mouse embryonic stem cells</article-title>. <source>Nat Cell Biol</source> <volume>22</volume>, <fpage>175</fpage>–<lpage>186</lpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><given-names>M.</given-names> <surname>Eckersley-Maslin</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Alda-Catalinas</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Blotenburg</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Kreibich</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Krueger</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Reik</surname></string-name>, <article-title>Dppa2 and Dppa4 directly regulate the Dux-driven zygotic transcriptional program</article-title>. <source>Genes Dev</source> <volume>33</volume>, <fpage>194</fpage>–<lpage>208</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><given-names>A.</given-names> <surname>De Iaco</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Coudray</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Duc</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Trono</surname></string-name>, <article-title>DPPA2 and DPPA4 are necessary to establish a 2C-like state in mouse embryonic stem cells</article-title>. <source>EMBO Rep</source> <volume>20</volume>, (<year>2019</year>).</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><given-names>P. G.</given-names> <surname>Hendrickson</surname></string-name>, <string-name><given-names>J. A.</given-names> <surname>Dorais</surname></string-name>, <string-name><given-names>E. J.</given-names> <surname>Grow</surname></string-name>, <string-name><given-names>J. L.</given-names> <surname>Whiddon</surname></string-name>, <string-name><given-names>J. W.</given-names> <surname>Lim</surname></string-name>, <string-name><given-names>C. L.</given-names> <surname>Wike</surname></string-name>, <string-name><given-names>B. D.</given-names> <surname>Weaver</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Pflueger</surname></string-name>, <string-name><given-names>B. R.</given-names> <surname>Emery</surname></string-name>, <string-name><given-names>A. L.</given-names> <surname>Wilcox</surname></string-name>, <string-name><given-names>D. A.</given-names> <surname>Nix</surname></string-name>, <string-name><given-names>C. M.</given-names> <surname>Peterson</surname></string-name>, <string-name><given-names>S. J.</given-names> <surname>Tapscott</surname></string-name>, <string-name><given-names>D. T.</given-names> <surname>Carrell</surname></string-name>, <string-name><given-names>B. R.</given-names> <surname>Cairns</surname></string-name>, <article-title>Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons</article-title>. <source>Nat Genet</source> <volume>49</volume>, <fpage>925</fpage>–<lpage>934</lpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><given-names>T.</given-names> <surname>Akiyama</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Xin</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Oda</surname></string-name>, <string-name><given-names>A. A.</given-names> <surname>Sharov</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Amano</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Piao</surname></string-name>, <string-name><given-names>J. S.</given-names> <surname>Cadet</surname></string-name>, <string-name><given-names>D. B.</given-names> <surname>Dudekula</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Qian</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>S. B.</given-names> <surname>Ko</surname></string-name>, <string-name><given-names>M. S.</given-names> <surname>Ko</surname></string-name>, <article-title>Transient bursts of Zscan4 expression are accompanied by the rapid derepression of heterochromatin in mouse embryonic stem cells</article-title>. <source>DNA Res</source> <volume>22</volume>, <fpage>307</fpage>–<lpage>318</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><given-names>X.</given-names> <surname>Fu</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>M. N.</given-names> <surname>Djekidel</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Zhang</surname></string-name>, <article-title>Myc and Dnmt1 impede the pluripotent to totipotent state transition in embryonic stem cells</article-title>. <source>Nat Cell Biol</source> <volume>21</volume>, <fpage>835</fpage>–<lpage>844</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><given-names>D.</given-names> <surname>Rodriguez-Terrones</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Gaume</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Ishiuchi</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Weiss</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Kopp</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Kruse</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Penning</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Vaquerizas</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Brino</surname></string-name>, <string-name><given-names>M. E.</given-names> <surname>Torres-Padilla</surname></string-name>, <article-title>A molecular roadmap for the emergence of early-embryonic-like cells in culture</article-title>. <source>Nat Genet</source> <volume>50</volume>, <fpage>106</fpage>–<lpage>119</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><given-names>M. A.</given-names> <surname>Eckersley-Maslin</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Svensson</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Krueger</surname></string-name>, <string-name><given-names>T. M.</given-names> <surname>Stubbs</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Giehr</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Krueger</surname></string-name>, <string-name><given-names>R. J.</given-names> <surname>Miragaia</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Kyriakopoulos</surname></string-name>, <string-name><given-names>R. V.</given-names> <surname>Berrens</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Milagre</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Walter</surname></string-name>, <string-name><given-names>S. A.</given-names> <surname>Teichmann</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Reik</surname></string-name>, <article-title>MERVL/Zscan4 Network Activation Results in Transient Genome-wide DNA Demethylation of mESCs</article-title>. <source>Cell Rep</source> <volume>17</volume>, <fpage>179</fpage>–<lpage>192</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><given-names>S.</given-names> <surname>Aranda</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Borras</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Sabido</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Di Croce</surname></string-name>, <article-title>Chromatin-Bound Proteome Profiling by Genome Capture</article-title>. <source>STAR Protoc</source> <volume>1</volume>, <issue>100014</issue> (<year>2020</year>).</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><given-names>S.</given-names> <surname>Aranda</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Alcaine-Colet</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Blanco</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Borras</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Caillot</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Sabido</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Di Croce</surname></string-name>, <article-title>Chromatin capture links the metabolic enzyme AHCY to stem cell proliferation</article-title>. <source>Sci Adv</source> <volume>5</volume>, <fpage>eaav2448</fpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><given-names>A.</given-names> <surname>De Iaco</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Planet</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Coluccio</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Verp</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Duc</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Trono</surname></string-name>, <article-title>DUX-family transcription factors regulate zygotic genome activation in placental mammals</article-title>. <source>Nat Genet</source> <volume>49</volume>, <fpage>941</fpage>–<lpage>945</lpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><given-names>G.</given-names> <surname>Falco</surname></string-name>, <string-name><given-names>S. L.</given-names> <surname>Lee</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Stanghellini</surname></string-name>, <string-name><given-names>U. C.</given-names> <surname>Bassey</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Hamatani</surname></string-name>, <string-name><given-names>M. S.</given-names> <surname>Ko</surname></string-name>, <article-title>Zscan4: a novel gene expressed exclusively in late 2-cell embryos and embryonic stem cells</article-title>. <source>Dev Biol</source> <volume>307</volume>, <fpage>539</fpage>–<lpage>550</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><given-names>F.</given-names> <surname>Lu</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Jiang</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Yamaguchi</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Zhang</surname></string-name>, <article-title>Role of Tet proteins in enhancer activity and telomere elongation</article-title>. <source>Genes Dev</source> <volume>28</volume>, <fpage>2103</fpage>–<lpage>2119</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><given-names>L.</given-names> <surname>Aloia</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Di Stefano</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Di Croce</surname></string-name>, <article-title>Polycomb complexes in stem cells and embryonic development</article-title>. <source>Development</source> <volume>140</volume>, <fpage>2525</fpage>–<lpage>2534</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><given-names>H.</given-names> <surname>Choi</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Larsen</surname></string-name>, <string-name><given-names>Z. Y.</given-names> <surname>Lin</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Breitkreutz</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Mellacheruvu</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Fermin</surname></string-name>, <string-name><given-names>Z. S.</given-names> <surname>Qin</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Tyers</surname></string-name>, <string-name><given-names>A. C.</given-names> <surname>Gingras</surname></string-name>, <string-name><given-names>A. I.</given-names> <surname>Nesvizhskii</surname></string-name>, <article-title>SAINT: probabilistic scoring of affinity purification-mass spectrometry data</article-title>. <source>Nat Methods</source> <volume>8</volume>, <fpage>70</fpage>–<lpage>73</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><given-names>J. C.</given-names> <surname>Wang</surname></string-name>, <article-title>Cellular roles of DNA topoisomerases: a molecular perspective</article-title>. <source>Nat Rev Mol Cell Biol</source> <volume>3</volume>, <fpage>430</fpage>–<lpage>440</lpage> (<year>2002</year>).</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><given-names>Y.</given-names> <surname>Pommier</surname></string-name>, <article-title>Topoisomerase I inhibitors: camptothecins and beyond</article-title>. <source>Nat Rev Cancer</source> <volume>6</volume>, <fpage>789</fpage>–<lpage>802</lpage> (<year>2006</year>).</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><given-names>C. S.</given-names> <surname>Downes</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Clarke</surname></string-name>, <string-name><given-names>A. M.</given-names> <surname>Mullinger</surname></string-name>, <string-name><given-names>J. F.</given-names> <surname>Gimenez-Abian</surname></string-name>, <string-name><given-names>A. M.</given-names> <surname>Creighton</surname></string-name>, <string-name><given-names>R. T.</given-names> <surname>Johnson</surname></string-name>, <article-title>A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells</article-title>. <source>Nature</source> <volume>372</volume>, <fpage>467</fpage>–<lpage>470</lpage> (<year>1994</year>).</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><given-names>H. M.</given-names> <surname>Robinson</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Bratlie-Thoresen</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Brown</surname></string-name>, <string-name><given-names>D. A.</given-names> <surname>Gillespie</surname></string-name>, <article-title>Chk1 is required for G2/M checkpoint response induced by the catalytic topoisomerase II inhibitor ICRF-193</article-title>. <source>Cell Cycle</source> <volume>6</volume>, <fpage>1265</fpage>–<lpage>1267</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><given-names>S. C.</given-names> <surname>Bantele</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Ferreira</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Gritenaite</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Boos</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Pfander</surname></string-name>, <article-title>Targeting of the Fun30 nucleosome remodeller by the Dpb11 scaffold facilitates cell cycle-regulated DNA end resection</article-title>. <source>Elife</source> <volume>6</volume>, (<year>2017</year>).</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><given-names>K.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Luo</surname></string-name>, <string-name><given-names>F. T.</given-names> <surname>Lin</surname></string-name>, <string-name><given-names>W. C.</given-names> <surname>Lin</surname></string-name>, <article-title>TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival</article-title>. <source>Genes Dev</source> <volume>18</volume>, <fpage>673</fpage>–<lpage>686</lpage> (<year>2004</year>).</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><given-names>A. H.</given-names> <surname>Peters</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Kubicek</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Mechtler</surname></string-name>, <string-name><given-names>R. J.</given-names> <surname>O’Sullivan</surname></string-name>, <string-name><given-names>A. A.</given-names> <surname>Derijck</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Perez-Burgos</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Kohlmaier</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Opravil</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Tachibana</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Shinkai</surname></string-name>, <string-name><given-names>J. H.</given-names> <surname>Martens</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Jenuwein</surname></string-name>, <article-title>Partitioning and plasticity of repressive histone methylation states in mammalian chromatin</article-title>. <source>Mol Cell</source> <volume>12</volume>, <fpage>1577</fpage>–<lpage>1589</lpage> (<year>2003</year>).</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><given-names>S.</given-names> <surname>Rea</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Eisenhaber</surname></string-name>, <string-name><given-names>D.</given-names> <surname>O’Carroll</surname></string-name>, <string-name><given-names>B. D.</given-names> <surname>Strahl</surname></string-name>, <string-name><given-names>Z. W.</given-names> <surname>Sun</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Schmid</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Opravil</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Mechtler</surname></string-name>, <string-name><given-names>C. P.</given-names> <surname>Ponting</surname></string-name>, <string-name><given-names>C. D.</given-names> <surname>Allis</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Jenuwein</surname></string-name>, <article-title>Regulation of chromatin structure by site-specific histone H3 methyltransferases</article-title>. <source>Nature</source> <volume>406</volume>, <fpage>593</fpage>–<lpage>599</lpage> (<year>2000</year>).</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><given-names>J.</given-names> <surname>Otterstrom</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Castells-Garcia</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Vicario</surname></string-name>, <string-name><given-names>P. A.</given-names> <surname>Gomez-Garcia</surname></string-name>, <string-name><given-names>M. P.</given-names> <surname>Cosma</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Lakadamyali</surname></string-name>, <article-title>Super-resolution microscopy reveals how histone tail acetylation affects DNA compaction within nucleosomes in vivo</article-title>. <source>Nucleic Acids Res</source> <volume>47</volume>, <fpage>8470</fpage>–<lpage>8484</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><given-names>P. J.</given-names> <surname>Zessin</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Finan</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Heilemann</surname></string-name>, <article-title>Super-resolution fluorescence imaging of chromosomal DNA</article-title>. <source>J Struct Biol</source> <volume>177</volume>, <fpage>344</fpage>–<lpage>348</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><given-names>L.</given-names> <surname>Andronov</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Orlov</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Lutz</surname></string-name>, <string-name><given-names>J. L.</given-names> <surname>Vonesch</surname></string-name>, <string-name><given-names>B. P.</given-names> <surname>Klaholz</surname></string-name>, <article-title>ClusterViSu, a method for clustering of protein complexes by Voronoi tessellation in super-resolution microscopy</article-title>. <source>Sci Rep</source> <volume>6</volume>, <issue>24084</issue> (<year>2016</year>).</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><given-names>F.</given-names> <surname>Levet</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Hosy</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Kechkar</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Butler</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Beghin</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Choquet</surname></string-name>, <string-name><given-names>J. B.</given-names> <surname>Sibarita</surname></string-name>, <article-title>SR-Tesseler: a method to segment and quantify localization-based super-resolution microscopy data</article-title>. <source>Nat Methods</source> <volume>12</volume>, <fpage>1065</fpage>–<lpage>1071</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><given-names>J.</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Yin</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Xiang</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Xia</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Ma</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Peng</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Zheng</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Ming</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Tian</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Xu</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Chang</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Na</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Yang</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Xie</surname></string-name>, <article-title>The landscape of accessible chromatin in mammalian preimplantation embryos</article-title>. <source>Nature</source> <volume>534</volume>, <fpage>652</fpage>–<lpage>657</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><given-names>P.</given-names> <surname>Sachs</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Ding</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Bergmaier</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Lamp</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Schlagheck</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Finkernagel</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Nist</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Stiewe</surname></string-name>, <string-name><given-names>J. E.</given-names> <surname>Mermoud</surname></string-name>, <article-title>SMARCAD1 ATPase activity is required to silence endogenous retroviruses in embryonic stem cells</article-title>. <source>Nat Commun</source> <volume>10</volume>, <fpage>1335</fpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><given-names>S. P.</given-names> <surname>Rowbotham</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Barki</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Neves-Costa</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Santos</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Dean</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Hawkes</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Choudhary</surname></string-name>, <string-name><given-names>W. R.</given-names> <surname>Will</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Webster</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Oxley</surname></string-name>, <string-name><given-names>C. M.</given-names> <surname>Green</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Varga-Weisz</surname></string-name>, <string-name><given-names>J. E.</given-names> <surname>Mermoud</surname></string-name>, <article-title>Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1</article-title>. <source>Mol Cell</source> <volume>42</volume>, <fpage>285</fpage>–<lpage>296</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><given-names>Q.</given-names> <surname>Deng</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Ramskold</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Reinius</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Sandberg</surname></string-name>, <article-title>Single-cell RNA-seq reveals dynamic, random monoallelic gene expression in mammalian cells</article-title>. <source>Science</source> <volume>343</volume>, <fpage>193</fpage>–<lpage>196</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><given-names>M.</given-names> <surname>Lachner</surname></string-name>, <string-name><given-names>D.</given-names> <surname>O’Carroll</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Rea</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Mechtler</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Jenuwein</surname></string-name>, <article-title>Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins</article-title>. <source>Nature</source> <volume>410</volume>, <fpage>116</fpage>–<lpage>120</lpage> (<year>2001</year>).</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><given-names>T.</given-names> <surname>Zhao</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Heyduk</surname></string-name>, <string-name><given-names>C. D.</given-names> <surname>Allis</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Eissenberg</surname></string-name>, <article-title>Heterochromatin protein 1 binds to nucleosomes and DNA in vitro</article-title>. <source>J Biol Chem</source> <volume>275</volume>, <fpage>28332</fpage>–<lpage>28338</lpage> (<year>2000</year>).</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><given-names>X.</given-names> <surname>Fu</surname></string-name>, <string-name><given-names>M. N.</given-names> <surname>Djekidel</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Zhang</surname></string-name>, <article-title>A transcriptional roadmap for 2C-like-to-pluripotent state transition</article-title>. <source>Sci Adv</source> <volume>6</volume>, <fpage>eaay5181</fpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><given-names>M.</given-names> <surname>Zernicka-Goetz</surname></string-name>, <string-name><given-names>S. A.</given-names> <surname>Morris</surname></string-name>, <string-name><given-names>A. W.</given-names> <surname>Bruce</surname></string-name>, <article-title>Making a firm decision: multifaceted regulation of cell fate in the early mouse embryo</article-title>. <source>Nat Rev Genet</source> <volume>10</volume>, <fpage>467</fpage>–<lpage>477</lpage> (<year>2009</year>).</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><given-names>D.</given-names> <surname>Rodriguez-Terrones</surname></string-name>, <string-name><given-names>M. E.</given-names> <surname>Torres-Padilla</surname></string-name>, <article-title>Nimble and Ready to Mingle: Transposon Outbursts of Early Development</article-title>. <source>Trends Genet</source> <volume>34</volume>, <fpage>806</fpage>–<lpage>820</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><given-names>M.</given-names> <surname>Friedli</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Trono</surname></string-name>, <article-title>The developmental control of transposable elements and the evolution of higher species</article-title>. <source>Annu Rev Cell Dev Biol</source> <volume>31</volume>, <fpage>429</fpage>–<lpage>451</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><given-names>H. M.</given-names> <surname>Rowe</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Jakobsson</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Mesnard</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Rougemont</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Reynard</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Aktas</surname></string-name>, <string-name><given-names>P. V.</given-names> <surname>Maillard</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Layard-Liesching</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Verp</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Marquis</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Spitz</surname></string-name>, <string-name><given-names>D. B.</given-names> <surname>Constam</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Trono</surname></string-name>, <article-title>KAP1 controls endogenous retroviruses in embryonic stem cells</article-title>. <source>Nature</source> <volume>463</volume>, <fpage>237</fpage>–<lpage>240</lpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><given-names>T.</given-names> <surname>Matsui</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Leung</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Miyashita</surname></string-name>, <string-name><given-names>I. A.</given-names> <surname>Maksakova</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Miyachi</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Kimura</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Tachibana</surname></string-name>, <string-name><given-names>M. C.</given-names> <surname>Lorincz</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Shinkai</surname></string-name>, <article-title>Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET</article-title>. <source>Nature</source> <volume>464</volume>, <fpage>927</fpage>–<lpage>931</lpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><given-names>D.</given-names> <surname>Wolf</surname></string-name>, <string-name><given-names>S. P.</given-names> <surname>Goff</surname></string-name>, <article-title>TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells</article-title>. <source>Cell</source> <volume>131</volume>, <fpage>46</fpage>–<lpage>57</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><given-names>D.</given-names> <surname>Ding</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Bergmaier</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Sachs</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Klangwart</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Ruckert</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Bartels</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Demmers</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Dekker</surname></string-name>, <string-name><given-names>R. A.</given-names> <surname>Poot</surname></string-name>, <string-name><given-names>J. E.</given-names> <surname>Mermoud</surname></string-name>, <article-title>The CUE1 domain of the SNF2-like chromatin remodeler SMARCAD1 mediates its association with KRAB-associated protein 1 (KAP1) and KAP1 target genes</article-title>. <source>J Biol Chem</source> <volume>293</volume>, <fpage>2711</fpage>–<lpage>2724</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><given-names>C.</given-names> <surname>Navarro</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Lyu</surname></string-name>, <string-name><given-names>A. M.</given-names> <surname>Katsori</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Caridha</surname></string-name>, <string-name><given-names>S. J.</given-names> <surname>Elsasser</surname></string-name>, <article-title>An embryonic stem cell-specific heterochromatin state promotes core histone exchange in the absence of DNA accessibility</article-title>. <source>Nat Commun</source> <volume>11</volume>, <fpage>5095</fpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><given-names>S.</given-names> <surname>Xiao</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Lu</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Sridhar</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Cao</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Yu</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Zhao</surname></string-name>, <string-name><given-names>C. C.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>D.</given-names> <surname>McDee</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Sloofman</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Rivas-Astroza</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Telugu</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Levasseur</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Liang</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Zhao</surname></string-name>, <string-name><given-names>T. S.</given-names> <surname>Tanaka</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Stormo</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Zhong</surname></string-name>, <article-title>SMARCAD1 Contributes to the Regulation of Naive Pluripotency by Interacting with Histone Citrullination</article-title>. <source>Cell Rep</source> <volume>18</volume>, <fpage>3117</fpage>–<lpage>3128</lpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><given-names>A.</given-names> <surname>Burton</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Brochard</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Galan</surname></string-name>, <string-name><given-names>E. R.</given-names> <surname>Ruiz-Morales</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Rovira</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Rodriguez-Terrones</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Kruse</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Le Gras</surname></string-name>, <string-name><given-names>V. S.</given-names> <surname>Udayakumar</surname></string-name>, <string-name><given-names>H. G.</given-names> <surname>Chin</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Eid</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Gao</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Pradhan</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Vaquerizas</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Beaujean</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Jenuwein</surname></string-name>, <string-name><given-names>M. E.</given-names> <surname>Torres-Padilla</surname></string-name>, <article-title>Heterochromatin establishment during early mammalian development is regulated by pericentromeric RNA and characterized by non-repressive H3K9me3</article-title>. <source>Nat Cell Biol</source> <volume>22</volume>, <fpage>767</fpage>–<lpage>778</lpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><given-names>C. A.</given-names> <surname>Seller</surname></string-name>, <string-name><given-names>C. Y.</given-names> <surname>Cho</surname></string-name>, <string-name><given-names>P. H.</given-names> <surname>O’Farrell</surname></string-name>, <article-title>Rapid embryonic cell cycles defer the establishment of heterochromatin by Eggless/SetDB1 in Drosophila</article-title>. <source>Genes Dev</source> <volume>33</volume>, <fpage>403</fpage>–<lpage>417</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><given-names>A.</given-names> <surname>Raulf</surname></string-name>, <string-name><given-names>C. K.</given-names> <surname>Spahn</surname></string-name>, <string-name><given-names>P. J.</given-names> <surname>Zessin</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Finan</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Bernhardt</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Heckel</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Heilemann</surname></string-name>, <article-title>Click chemistry facilitates direct labelling and super-resolution imaging of nucleic acids and proteinsdaggerElectronic supplementary information (ESI) available</article-title>. See DOI: <pub-id pub-id-type="doi">10.1039/c4ra01027bClick</pub-id> here for additional data file. <source>RSC Adv</source> <volume>4</volume>, <fpage>30462</fpage>-<lpage>30466</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><given-names>M.</given-names> <surname>Bates</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>G. T.</given-names> <surname>Dempsey</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Zhuang</surname></string-name>, <article-title>Multicolor super-resolution imaging with photo-switchable fluorescent probes</article-title>. <source>Science</source> <volume>317</volume>, <fpage>1749</fpage>–<lpage>1753</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><given-names>M. J.</given-names> <surname>Rust</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Bates</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Zhuang</surname></string-name>, <article-title>Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM)</article-title>. <source>Nat Methods</source> <volume>3</volume>, <fpage>793</fpage>–<lpage>795</lpage> (<year>2006</year>).</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><given-names>J. R.</given-names> <surname>Wisniewski</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Zougman</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Nagaraj</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Mann</surname></string-name>, <article-title>Universal sample preparation method for proteome analysis</article-title>. <source>Nat Methods</source> <volume>6</volume>, <fpage>359</fpage>–<lpage>362</lpage> (<year>2009</year>).</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><given-names>C.</given-names> <surname>Chiva</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Olivella</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Borras</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Espadas</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Pastor</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Sole</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Sabido</surname></string-name>, <article-title>QCloud: A cloud-based quality control system for mass spectrometry-based proteomics laboratories</article-title>. <source>PLoS One</source> <volume>13</volume>, <issue>e0189209</issue> (<year>2018</year>).</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><string-name><given-names>D. N.</given-names> <surname>Perkins</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Pappin</surname></string-name>, <string-name><given-names>D. M.</given-names> <surname>Creasy</surname></string-name>, <string-name><given-names>J. S.</given-names> <surname>Cottrell</surname></string-name>, <article-title>Probability-based protein identification by searching sequence databases using mass spectrometry data</article-title>. <source>Electrophoresis</source> <volume>20</volume>, <fpage>3551</fpage>–<lpage>3567</lpage> (<year>1999</year>).</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><given-names>H.</given-names> <surname>Nolte</surname></string-name>, <string-name><given-names>T. D.</given-names> <surname>MacVicar</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Tellkamp</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Kruger</surname></string-name>, <article-title>Instant Clue: A Software Suite for Interactive Data Visualization and Analysis</article-title>. <source>Sci Rep</source> <volume>8</volume>, <issue>12648</issue> (<year>2018</year>).</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><given-names>H.</given-names> <surname>Mi</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Muruganujan</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Ebert</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>P. D.</given-names> <surname>Thomas</surname></string-name>, <article-title>PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools</article-title>. <source>Nucleic Acids Res</source> <volume>47</volume>, <fpage>D419</fpage>–<lpage>D426</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><given-names>M.</given-names> <surname>Ashburner</surname></string-name>, <string-name><given-names>C. A.</given-names> <surname>Ball</surname></string-name>, <string-name><given-names>J. A.</given-names> <surname>Blake</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Botstein</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Butler</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Cherry</surname></string-name>, <string-name><given-names>A. P.</given-names> <surname>Davis</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Dolinski</surname></string-name>, <string-name><given-names>S. S.</given-names> <surname>Dwight</surname></string-name>, <string-name><given-names>J. T.</given-names> <surname>Eppig</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Harris</surname></string-name>, <string-name><given-names>D. P.</given-names> <surname>Hill</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Issel-Tarver</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Kasarskis</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Lewis</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Matese</surname></string-name>, <string-name><given-names>J. E.</given-names> <surname>Richardson</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Ringwald</surname></string-name>, <string-name><given-names>G. M.</given-names> <surname>Rubin</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Sherlock</surname></string-name>, <article-title>Gene ontology: tool for the unification of biology. The Gene Ontology Consortium</article-title>. <source>Nat Genet</source> <volume>25</volume>, <fpage>25</fpage>–<lpage>29</lpage> (<year>2000</year>).</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><given-names>D.</given-names> <surname>Szklarczyk</surname></string-name>, <string-name><given-names>J. H.</given-names> <surname>Morris</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Cook</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Kuhn</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Wyder</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Simonovic</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Santos</surname></string-name>, <string-name><given-names>N. T.</given-names> <surname>Doncheva</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Roth</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Bork</surname></string-name>, <string-name><given-names>L. J.</given-names> <surname>Jensen</surname></string-name>, <string-name><given-names>C.</given-names> <surname>von Mering</surname></string-name>, <article-title>The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible</article-title>. <source>Nucleic Acids Res</source> <volume>45</volume>, <fpage>D362</fpage>–<lpage>D368</lpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><string-name><given-names>P.</given-names> <surname>Shannon</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Markiel</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Ozier</surname></string-name>, <string-name><given-names>N. S.</given-names> <surname>Baliga</surname></string-name>, <string-name><given-names>J. T.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Ramage</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Amin</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Schwikowski</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Ideker</surname></string-name>, <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome Res</source> <volume>13</volume>, <fpage>2498</fpage>–<lpage>2504</lpage> (<year>2003</year>).</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><given-names>Y.</given-names> <surname>Perez-Riverol</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Csordas</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Bai</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Bernal-Llinares</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Hewapathirana</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Kundu</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Inuganti</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Griss</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Mayer</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Eisenacher</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Perez</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Uszkoreit</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Pfeuffer</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Sachsenberg</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Yilmaz</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Tiwary</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Cox</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Audain</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Walzer</surname></string-name>, <string-name><given-names>A. F.</given-names> <surname>Jarnuczak</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Ternent</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Brazma</surname></string-name>, <string-name><given-names>J. A.</given-names> <surname>Vizcaino</surname></string-name>, <article-title>The PRIDE database and related tools and resources in 2019: improving support for quantification data</article-title>. <source>Nucleic Acids Res</source> <volume>47</volume>, <fpage>D442</fpage>–<lpage>D450</lpage> (<year>2019</year>).</mixed-citation></ref>
</ref-list>
<sec>
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Fig. S1.</label>
<caption><title>Characterization of Dux-derived 2C-like cells</title>
<p>(<bold>A</bold>) Representative live-cell images of stable luciferase and Dux-CA ESC lines upon doxycycline (Dox) induction. Scale bar, 20 µm. (<bold>B</bold>) Representative immunofluorescence images of the 2C::EGFP reporter in the Dux-CA line in control (-Dox) and Dux overexpressing (+Dox) conditions showing activation of the 2C::EGFP reporter after 24 h of Dox administration. Scale bar, 50 µm. (<bold>C</bold>) Representative FACS plots showing GFP<sup>+</sup> cells in the Dux-CA line without (-Dox) and after 24 h of Dox treatment (+Dox). (<bold>D</bold>) Effect of Dux overexpression on the activation of the 2C::EGFP reporter by flow cytometry. Data are presented as mean ± SD (n = 3 independent cultures). <italic>P</italic> &lt; 0.0001**** by one-way ANOVA (Tukey’s multiple comparisons test). (<bold>E</bold>) Representative immunofluorescence images out of two experiments of the 2C::EGFP reporter and the endogenous pluripotency transcription factor OCT4 after 24 h of Dox induction. Arrowheads indicate 2C<sup>+</sup> cells. Dashed lines indicate nuclei contour. Scale bar, 5 µm. (<bold>F</bold>) qRT-PCR of <italic>Dux</italic>, MERVL and major satellites (MajSat) in ESCs, 2C<sup>−</sup> and 2C<sup>+</sup> sorted cells. Data are presented as mean ± SE (n ≥ 2, 2C<sup>−</sup> and 2C<sup>+</sup> samples are technical replicates). (<bold>G</bold>) Cell cycle profile of non-induced luciferase (Luc) control ESCs, 2C<sup>−</sup> and 2C<sup>+</sup> cells (left). Quantification of the percentage of ESCs, 2C<sup>−</sup> and 2C<sup>+</sup> cells in different phases of the cell cycle (right). Data are presented as mean ± SD (n &gt; 3 independent cultures). <italic>P</italic> &gt; 0.05<sup>ns</sup>, <italic>P</italic> = 0.0289*, <italic>P</italic> &lt; 0.0001**** by two-way ANOVA (Dunnett’s multiple comparisons test). (<bold>H</bold>) Quantification of the percentage of control ESCs (Ctrl) and 2C<sup>+</sup> cells in different phases of the cell cycle. 2C<sup>+</sup> cells induced from several Dux overexpressing clonal lines generated in our laboratory were analyzed. An independent Dux-CA clonal line was included for comparison, ref. Hendrickson et al., 2017. Data are presented as mean ± SE (n ≥ 3, technical replicates).</p></caption>
<graphic xlink:href="537018v1_figs1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Fig. S2.</label>
<caption><title>Chromatin proteomics of 2C-like cells</title>
<p>(<bold>A</bold>) Independent DNA-mediated chromatin pull-down (iPOTD) eluates from sorted luciferase, 2C<sup>−</sup> and 2C<sup>+</sup> replicates in the absence or presence of EdU (±EdU) were analyzed by dot blot with an anti-H3 antibody (left). Input and eluates from equivalent preparations were incubated with an anti-vinculin antibody (right). Each condition was spotted in triplicates. (<bold>B</bold>) Quantification of histone H3 signal detected by dot blot in the absence or presence of EdU. Data are presented as mean ± SD of H3 signal normalized to the background. (<bold>C</bold>) Quantification of vinculin (Vinc) signal detected by dot blot in input or iPOTD samples. Data are presented as mean ± SD of vinculin signal normalized to the background. (<bold>D</bold>) Volcano plot of proteins identified by mass-spectrometry after DNA-mediated chromatin pull-down in Luc and – EdU conditions. 2396 proteins were enriched in the Luc (+EdU) chromatome compared with the control –EdU condition (fold change &gt; 1). (<bold>E</bold>) Abundance of histones in the individual replicates from –EdU, Luc, 2C<sup>−</sup> and 2C<sup>+</sup> conditions. The following histones were included in the analysis: core histones H2A, H2B and H4, macro-H2A.1, macro-H2A.2, H2A.V, H2A.X, H3.3 and CENP-A. Violin plot shows median with a solid line and quartiles with dashed lines.</p></caption>
<graphic xlink:href="537018v1_figs2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs3" position="float" orientation="portrait" fig-type="figure">
<label>Fig. S3.</label>
<caption><title>Pharmacological and genetic perturbations in 2C-like cells</title>
<p>(<bold>A</bold>) Quantification of the percentage of 2C<sup>+</sup> cells after inhibition of DNA topoisomerase I (TopoI inhib.), DNA topoisomerase II (TopoII inhib.) or its combined inhibition. Data are presented as scatter dot plots with line at mean ± SD (n ≥ 3 independent experiments). <italic>P</italic> = 0.0421*, <italic>P</italic> &lt; 0.0001**** by one-way ANOVA (Tukey’s multiple comparisons test). (<bold>B</bold>) Cell cycle profile of DMSO and DNA topoisomerase II inhibited ESCs. (<bold>C</bold>) Representative FACS plots showing GFP<sup>+</sup> cells in DMSO and double DNA topoisomerase inhibition conditions. (<bold>D</bold>) Representative Western Blots for luciferase (Luc), 2C<sup>−</sup> and 2C<sup>+</sup> cells. SMARCAD1, OCT4, H3K9me3 and total histone H3 blots are shown. (<bold>E</bold>) qRT-PCR of <italic>Smarcad1</italic> in control luciferase (sgLuc) and <italic>Smarcad1</italic>-targeted (sgSmarcad1) mCherry<sup>+</sup> sorted ESCs 48 h after CRISPR-Cas9 sgRNA delivery. Data are presented as mean ± SD from two replicates transfected in independent rounds of sgRNA delivery. Independent sgRNAs targeting the same target gene were used in each round. (<bold>F</bold>) Quantification of the percentage of 2C-like cells 24 h, 48 h and 72 h after 2C<sup>+</sup> cell sorting in non-transfected (NT) and luciferase-targeted (sgLuc) ESCs. Data are presented as mean ± SD. <italic>P</italic> &gt; 0.05<sup>ns</sup>, <italic>P</italic> = 0.0463* by two-way ANOVA (Sidak’s multiple comparisons test).</p></caption>
<graphic xlink:href="537018v1_figs3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs4" position="float" orientation="portrait" fig-type="figure">
<label>Fig. S4.</label>
<caption><title>H3K9me3 foci analysis in <italic>Smarcad1</italic> and <italic>Topbp1</italic> knockdown ESCs, 2C<sup>−</sup> and 2C<sup>+</sup> cells.</title>
<p><bold>(A)</bold> qRT-PCR of <italic>Smarcad1</italic> and <italic>Topbp1</italic> in <italic>Smarcad1</italic> knockdown (shSmarcad1), <italic>Topbp1</italic> knockdown (shTopbp1 #1 and shTopbp1 #2) and control scramble (shScbl) ESCs. Data are presented as mean ± SD (n = 3 independent experiments). <italic>P</italic> = 0.0268*, <italic>P</italic> = 0.0010**, <italic>P</italic> = 0.0020** by one-way ANOVA (Dunnett’s multiple comparisons test). (<bold>B</bold>) Quantification of the number of H3K9me3 foci in shScbl, shSmarcad1, shTopbp1 #1 and shTopbp1 #2 ESCs. Data are presented as scatter dot plots with line at median ± interquartile range (n &gt; 3 independent cultures; shScbl = 90 cells, shSmarcad1 = 25 cells, shTopbp1 #1 = 81 cells and shTopbp1 #2 = 22 cells). <italic>P</italic> = 0.0009***, <italic>P</italic> = 0.0217*, <italic>P</italic> &lt; 0.0001**** by Mann-Whitney test. (<bold>C</bold>) Quantification of H3K9me3 foci area in shScbl, shSmarcad1, shTopbp1 #1 and shTopbp1 #2 ESCs. Data are presented as scatter dot plots with line at median ± interquartile range (n &gt; 3 independent cultures; shScbl = 1241 foci, shSmarcad1 = 281 foci, shTopbp1 #1 = 1004 foci and shTopbp1 #2 = 225 foci). <italic>P</italic> = 0.0016**, <italic>P</italic> = 0.2260<sup>ns</sup>, <italic>P</italic> = 0.0103* by Mann-Whitney test. (<bold>D</bold>) Representative immunofluorescence images of H3K9me3 and the 2C::EGFP reporter during the ESCs to 2C<sup>+</sup> reprogramming in <italic>Smarcad1</italic> knockdown (shSmarcad1), <italic>Topbp1</italic> knockdown (shTopbp1 #1 and shTopbp1 #2) and control scramble (shScbl) cells. Scale bar, 2 μm. (<bold>E</bold>) Representative immunofluorescence images of H3K9me3, SMARCAD1 and the 2C::EGFP reporter during the 2C<sup>+</sup> exit (24 h, 48 h and 72 h) in <italic>Topbp1</italic> knockdown (shTopbp1 #1) and control scramble (shScbl) cells. Scale bar, 5 μm. (<bold>F</bold>) Quantification of the number of H3K9me3 foci in 2C<sup>+</sup> cells in shScbl and shTopbp1 #1 (shTop#1) samples at 0 h, 24 h, 48 h and 72 h after 2C-like state exit. Data are presented as scatter dot plots with line at median ± interquartile range (n = 2 independent cultures; shScbl 0 h = 49 cells, shTop#1 0 h = 30 cells, shScbl 24 h = 13 cells, shTop#1 24 h = 12 cells, shScbl 48 h = 18 cells, shTop#1 48 h = 48 cells, shScbl 72 h = 83 cells, shTop#1 72 h = 515 cells). <italic>P</italic> = 0.0086**, <italic>P</italic> = 0.1546<sup>ns</sup>, <italic>P</italic> &lt; 0.0001****, <italic>P</italic> &lt; 0.0001**** by Mann-Whitney test. (<bold>G)</bold> Quantification of H3K9me3 foci area in 2C<sup>+</sup> cells in shScbl and shTopbp1 #1 (shTop#1) samples at 0 h, 24 h, 48 h and 72 h after 2C-like state exit. Data are presented as scatter dot plots with line at median ± interquartile range (n = 2 independent cultures; shScbl 0 h = 342 foci, shTop#1 0 h = 304 foci, shScbl 24 h = 481 foci, shTop#1 24 h = 158 foci, shScbl 48 h = 537 foci, shTop#1 48 h = 271 foci, shScbl 72 h = 2634 foci, shTop#1 72 h = 3477 foci). <italic>P</italic> = 0.1037<sup>ns</sup>, <italic>P</italic> = 0.0163*, <italic>P</italic> = 0.0002***, <italic>P</italic> &lt; 0.0001**** by Mann-Whitney test.</p></caption>
<graphic xlink:href="537018v1_figs4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs5" position="float" orientation="portrait" fig-type="figure">
<label>Fig. S5.</label>
<caption><title>SMARCAD1 downregulation in mouse embryos</title>
<p>(<bold>A</bold>) Schematic representation of the experimental design to assess SMARCAD1 and TOPBP1 function in early mouse embryo development. Morpholino antisense oligos (MO) targeting <italic>Smarcad1</italic>, <italic>Topbp1</italic> and a scrambled control (Ctrl) sequence were microinjected into the cytoplasm of zygotes (E0.5 embryos). Embryo development was monitored daily from the 2-cell stage (E1.5) until the late blastocyst stage (E5.5). (<bold>B</bold>) Representative immunofluorescence images of SMARCAD1 in Ctrl and <italic>Smarcad1</italic> MO embryos at 2-cell (E1.5) and 8-cell stage (E2.5) embryos. Representative blastomere nuclei are shown. Scale bar, 5 µm. (<bold>C</bold>) Quantification of SMARCAD1 mean fluorescence intensity in Ctrl and <italic>Smarcad1</italic>MO embryos at 2-cell (E1.5) and 8-cell stage (E2.5). Data are presented as scatter dot plots with line at mean ± SD (2-cell: Ctrl MO = 8 embryos, <italic>Smarcad1</italic> MO = 15 embryos; 8-cell: Ctrl MO = 11 embryos, <italic>Smarcad1</italic> MO = 15 embryos). SMARCAD1 signal was normalized to the average background signal. <italic>P</italic> &lt; 0.0001**** by unpaired two-tailed Student’s <italic>t</italic>-test. (<bold>D</bold>) Representative immunofluorescence images of H3K9me3 in Ctrl and <italic>Topbp1</italic> MO embryos at 4-cell (E2.0) embryos. Representative blastomere nuclei are shown. Scale bar, 5 µm. (<bold>E</bold>) Quantification of H3K9me3 mean fluorescence intensity in Ctrl and <italic>Topbp1</italic> MO embryos at 4-cell (E 2.0) embryos. Data are presented as scatter dot plots with line at mean ± SD (Ctrl MO = 35 embryos, <italic>Topbp1</italic> MO = 27 embryos). H3K9me3 signal was normalized to the average background signal. (<bold>F</bold>) Representative immunofluorescence images of HP1b in Ctrl and <italic>Topbp1</italic> MO embryos at 2-cell (E1.5) embryos. Representative blastomere nuclei are shown. Scale bar, 10 µm. (<bold>G</bold>) Quantification of HP1b mean fluorescence intensity in Ctrl and <italic>Topbp1</italic> MO embryos at 2-cell (E1.5). Data are presented as scatter dot plots with line at mean ± SD (Ctrl MO = 20 embryos, <italic>Topbp1</italic> MO = 21 embryos). HP1b signal was normalized to the average background signal. <italic>P</italic> &lt; 0.0001**** by unpaired two-tailed Student’s <italic>t</italic>-test. (<bold>H</bold>) Representative immunofluorescence images of HP1b in Ctrl and <italic>Topbp1</italic> MO embryos at 4-cell (E2.0) embryos. Representative blastomere nuclei are shown. Scale bar, 10 µm. (<bold>I</bold>) Quantification of HP1b mean fluorescence intensity in Ctrl and <italic>Topbp1</italic> MO embryos at 4-cell (E2.0). Data are presented as scatter dot plots with line at mean ± SD (Ctrl MO = 16 embryos, <italic>Topbp1</italic> MO = 13 embryos). HP1b signal was normalized to the average background signal. <italic>P</italic> &lt; 0.0001**** by unpaired two-tailed Student’s <italic>t</italic>-test. (<bold>J</bold>) Quantification of SMARCAD1 mean fluorescence intensity in Ctrl and <italic>Topbp1</italic> MO embryos arrested at 2-cell and 4-cell stage (E2.0). Data are presented as scatter dot plots with line at mean ± SD (Ctrl MO = 20 embryos, <italic>Topbp1</italic> MO = 31 embryos). SMARCAD1 signal was normalized to the average background signal. <italic>P</italic> &lt; 0.0001**** by unpaired two-tailed Student’s <italic>t</italic>-test. (<bold>K</bold>) Quantification of SMARCAD1 mean fluorescence intensity in Ctrl and <italic>Topbp1</italic> MO embryos arrested at 2-cell stage. Data are presented as scatter dot plots with line at mean ± SD (Ctrl MO = 20 embryos, <italic>Topbp1</italic> MO = 21 embryos). SMARCAD1 signal was normalized to the average background signal. <italic>P</italic> &lt; 0.0001**** by unpaired two-tailed Student’s <italic>t</italic>-test. (<bold>L</bold>) Quantification of SMARCAD1 mean fluorescence intensity in Ctrl and <italic>Topbp1</italic> MO embryos arrested at 4-cell stage. Data are presented as scatter dot plots with line at mean ± SD (Ctrl MO = 20 embryos, <italic>Topbp1</italic> MO = 11 embryos). SMARCAD1 signal was normalized to the average background signal. <italic>P</italic> &lt; 0.0174* by unpaired two-tailed Student’s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="537018v1_figs5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.87742.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Postovit</surname>
<given-names>Lynne-Marie</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Queens University</institution>
</institution-wrap>
<city>Kingston</city>
<country>Canada</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Incomplete</kwd>
<kwd>Solid</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>important</bold> study increases our understanding of the role of heterochromatin domain dynamics during early embryonic development by annotating the change in chromatin-associated proteins as a function of cell state. The authors provide <bold>solid</bold> evidence to demonstrate that DNA Topoisomerase II Binding protein (TOPBP1) is an ESC-specific chromatin-bound factor that potentially regulates chromocenter reorganization during the 2CLC-ESC transition through interaction with the SWI/SNF complex component SMARCAD1. However, a lack of mechanistic studies to interrogate how TOPBP1 and SMARCAD1 contribute to the reorganization of H3K9me3-heterochromatin or chromocenter concomitant with alterations in stem cell state leaves the current work <bold>incomplete</bold>.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.87742.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>In the present work the authors explore the molecular driving events involved in the establishment of constitutive heterochromatin during embryo development. The experiments have been carried out in a very accurate manner and clearly fulfill the proposed hypotheses.</p>
<p>Regarding the methodology, the use of: i) an efficient system for conversion of ESCs to 2C-like cells by Dux overexpression; ii) a global approach through IPOTD that reveals the chromatome at each stage of development and iii) the STORM technology that allows visualization of DNA decompaction at high resolution, helps to provide clear and comprehensive answers to the conclusion raised.</p>
<p>The contribution of the present work to the field is very important as it provides valuable information on chromatin-bound proteins at key stages of embryonic development that may help to understand other relevant processes beyond heterochromatin maintenance.</p>
<p>The study could be improved through a more mechanistic approach that focuses on how SMARCAD1 and TOPBP1 cooperate and how they functionally connect with H3K9me3, HP1b and heterochromatin regulation during embryonic development. For example, addressing why topoisomerase activity is required or whether it connects (or not) to SWI/SNF function and the latter to heterochromatin establishment, are questions that would help to understand more deeply how SMARCAD1 and TOPBP1 operate in embryonic development.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.87742.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>The manuscript by Sebastian-Perez describes determinants of heterochromatin domain formation (chromocenters) at the 2-cell stage of mouse embryonic development. They implement an inducible system for transition from ESC to 2C-like cells (referred to as 2C+) together with proteomic approaches to identify temporal changes in associated proteins. The conversion of ESCs to 2C+ is accompanied by dissolution of chromocenter domains marked by HP1b and H3K9me3, which reform upon transition back to the 2C-like state. The innovation in this study is the incorporation of proteomic analysis to identify chromatin-associated proteins, which revealed SMARCAD1 and TOPBP1 as key regulators of chromocenter formation.</p>
<p>In the model system used, doxycycline induction of DUX leads to activation of EGFP reporter regulated by the MERVL-LTR in 2C+ cells that can be sorted for further analysis. A doxycycline-inducible luciferase cell line is used as a control and does not activate the MERVL-LTR GFP reporter. The authors do see groups of proteins anticipated for each developmental stage that suggest the overall strategy is effective.</p>
<p>The major strengths of the paper involve the proteomic screen and initial validation. From there, however, the focus on TOPBP1 and SMARCAD1 is not well justified. In addition, how data is presented in the results section does not follow a logical flow. Overall, my suggestion is that these structural issues need to be resolved before engaging in comprehensive review of the submission. This may be best achieved by separating the proteomic/morphological analyses from the characterization of TOPBP1 and SMARCAD1.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.87742.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>The manuscript entitled &quot;SMARCAD1 and TOPBP1 contribute to heterochromatin maintenance at the transition from the 2C-like to the pluripotent state&quot; by Sebastian-Perez et al. adopted the iPOTD method to compare the chromatin-bound proteome in ESCs and 2C-like cells generated by Dux overexpression. The authors identified 397 chromatin-bound proteins enriched only in ESC and 2C- cells, among which they further investigated TOPBP1 due to its potential role in controlling chromocenter reorganization. SMARCD1, a known interacting protein of TOPBP1, was also investigated in parallel. The authors observed increased size and decreased number of H3K9me3-heterochromatin foci in Dux-induced 2C+ cells. Interestingly, depletion of TOPBP1 or SMARCD1 also led to increased size and decreased number of H3K9me3 foci. However, depletion of these proteins did not affect entry into or exit from the 2C-like state. Nevertheless, the authors showed that both TOPBP1 and SMARCD1 are required for early embryonic development.</p>
<p>Although this manuscript provides new insights into the features of 2C-like cells regarding H3K9me3-heterochromatin reorganization, it remains largely descriptive at this stage. It does not provide new insights into the following important aspects: 1) how SMARCD1 associates with H3K9me3 and contributes to heterochromatin maintenance, 2) how TOPBP1 regulates the expression of SMARCD1 and facilitates its localization in heterochromatin foci, 3) whether the remodelling of chromocenter is causally related to the mutual transitions between ESCs and 2C-like cells. Furthermore, some results are over-interpreted. Additional experiments and analyses are needed to increase the strength of mechanistic insights and to support all claims in the manuscript.</p>
</body>
</sub-article>
</article>